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Resumo 
Este trabalho teve como objectivo a síntese e o estudo de nanopartículas magnéticas 
de óxidos de ferro (MNPs) revestidas com diferentes polímeros, e a sua posterior 
modificação com enzimas e ligandos sintéticos de afinidade de modo a explorar as 
suas potenciais aplicações na área da biocatálise e bioseparação. 
A adsorção dos biopolímeros - Goma arábica (Ga), Dextrano (Dex) e Polissacárido 
Extracelular (EPS) - foi efectuada durante a síntese das partículas e a quantidade de 
polímero adsorvido foi determinado e comparado com os perfis de adsorção de cada 
polímero. A estabilidade dos suportes magnéticos ao armazenamento e à modificação 
química foi estudada, tendo-se observado uma elevada estabilidade dos suportes. 
A potencial aplicação destes suportes magnéticos em biocatálise foi estudada através 
da imobilização de uma enzima, Enterocinase (EK), por duas vias químicas distintas. 
Após imobilização, a actividade enzimática da EK nos suportes magnéticos foi testada 
com um substrato sintético e duas proteínas de fusão. Após a imobilização da enzima 
observou-se uma diminuição da sua actividade, que foi compensada pela sua 
reutilização até dez vezes. O suporte magnético mais promissor foram as MNP_Dex, 
apresentando uma retenção de actividade de 35% e uma percentagem de conversão de 
0,4% no primeiro ciclo de reacção. 
A utilização dos suportes magnéticos em processos de bioseparação de IgG foi testada 
através da imobilização do ligando sintético de afinidade 22/8 às partículas 
modificadas com biopolímeros, por três diferentes métodos. As MNP_Dex modificadas 
com o ligando sintetizado directamente no suporte adsorvem cerca de 130 mg IgG/g de 
MNP e são o suporte que apresenta menor adsorção inespecífica. Para além disso, este 
suporte revelou ainda especificidade e capacidade de adsorver IgG e seus fragmentos 
de extractos brutos de proteínas expressas por leveduras e células mamíferas. 
Termos Chave: partículas magnéticas; biopolímeros; clivagem enzimática; ligandos 
de afinidade; purificação. 
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Abstract 
This work aimed to prepare iron oxide magnetic nanoparticles (MNPs) coated with 
biopolymers and further modified with enzymes and synthetic affinity ligands in order 
to study their applications in biocatalysis and bioseparation areas. 
The adsorption of different biopolymers - Gum Arabic (Ga), Dextran (Dex) and 
Extracellular Polysaccharide (EPS) - was performed during the synthesis of the 
particles, and the amount of polymer bound was determined and compared to the 
adsorption profiles of each polymer. Additionally, the storage and chemical 
modification stability of these supports was also evaluated. All supports showed high 
stability. 
The eventual application of these magnetic supports in biocatalysis was evaluated 
through the immobilization of an enzyme, Enterokinase (EK), through two distinct 
chemistries. The enzyme was then tested with a synthetic substrate and two fusion 
proteins. After the enzyme’s immobilization, its activity was observed to decrease, 
which was compensated by its re-utilization up to ten times. The most promising 
magnetic support was the MNP_Dex since it presented an activity retention of 35% 
and a conversion percentage of 0.4% in the first reaction cycle. 
The utilization of magnetic supports for the purification of IgG was tested through the 
immobilization of the synthetic affinity ligand 22/8 using three different methods. The 
MNP_Dex support modified with the ligand synthesized directly on the solid support 
adsorbed around 130 mg of IgG/g of MNP and presented less nonspecific adsorption. 
Moreover, this support presented specificity and capability to adsorb IgG and its 
fragments from crude extracts expressed in yeast and mammalian cells. 
Keywords: magnetic nanoparticles; biopolymers; enzyme cleavage; affinity ligands; 
purification. 
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1 LITERATURE REVIEW 
This first chapter describes the unique properties and some applications of 
magnetic nanoparticles. In particular, the advantages of implementing these 
materials in the biocatalysis and bioseparation fields  are discussed. Finally, 
the motivation for this work is presented. 
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1.1 Nanotechnology as an emerging field 
In recent years, most of the technological revolutions have focused on the ability to 
create products with smaller dimensions, but with higher precision. This principle is 
particularly true at the level of nanotechnology (deMello and Woolley, 2010). Thus, 
nanotechnology refers to the creation and use of materials, devices and systems 
through control of matter at the nanoscale, to create new materials with different 
functional characteristics of the common materials. It is defined by the National 
Nanotechnology Initiative (NNI) as the understanding of matter at dimensions of 
roughly 1 to 100 nm as a unique phenomenon that enables new applications (Roco, 
2004). Nanotechnology is a multidisciplinary field, combining different knowledge 
areas such as chemistry, physics, biology and engineering (Roco, 2004; Fatehi et al., 
2011). 
In order to develop nanotechnology two approaches can be followed: the bottom - up 
strategy, which involves the assembly of smaller units to obtain a larger structures and 
the top – down strategy, which involves ultra-miniaturization from larger materials 
(Ramsden, 2005; Shoseyov and Levy, 2008). Through the bottom – up strategy appears 
the nanobiotechnology concept, which is defined as the incorporation of nanoscale 
devices into biological organisms in order to improve monitoring, regulation and 
characterization of the biological processes and systems (Shoseyov and Levy, 2008; 
Amin et al., 2011). 
Overall, nanotechnology is an interdisciplinary area with great potential to create new 
discoveries in main areas such as materials, nanoelectronics, medicine and healthcare, 
biotechnology and information technology, as well as, to bring together different fields 
of science (Bhushan, 2004; deMello and Woolley, 2010; Amin et al., 2011). 
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1.2 Magnetic Nanoparticles 
In the last decades the interest in the use of nanomaterials, in special nanoparticles, 
has increased markedly because these materials combine the fields of material science 
and biology with a view of numerous technological applications (De et al., 2008). The 
growing interest in nanoparticles comes from the fact that these materials possess 
unique properties dependent on their size and also can be modified with different 
materials and biomolecules (Liu, 2006; De et al., 2008). A considerable emphasis has 
been given to Magnetic Nanoparticles (MNPs) due to their properties, especially the 
superparamagnetic phenomena which have found remarkable applications in different 
areas (Safarik and Safarikova, 2009). 
1.2.1 Magnetic Nanoparticles and their Properties 
Iron oxide nanoparticles are an important class of inorganic nanomaterials being the 
most promising materials of this class the magnetite (Fe3O4) and maghemite (γ – 
Fe2O3) due to their biocompatibility (Gupta and Gupta, 2005; Wu et al., 2008; Boyer et 
al., 2010). The magnetite material presents a tetrahedrally - octahedrally coordinated 
structure with the iron atoms coordinated with oxygen atoms (Grillo et al., 2008). 
These particles act as Lewis acids because the iron atoms can coordinate with 
molecules that donate lone-pair electrons (Laurent et al., 2008; Dias et al., 2011). So, 
depending on the medium in which the MNPs are dissolved the surface charge varies, 
considering an isoelectric point around pH 6.8. Consequently, below isoelectric point 
occurs protonation of the particles and H+ coordinate to the oxygen atoms and the 
surface became positively charged. On the other hand above the isoelectric point 
desprotonation occurs and leads to the formation of a negatively charged surface. At 
neutral solutions Fe-OH groups are formed and the charge of the surface of the 
particles slightly decreases (JianHan et al., 2007; Dias et al., 2011). 
MNPs attract attention due to their distinguished features such as 
superparamagnetism, no coercitivity, and high magnetic susceptibility. These 
superparamagnetic properties correspond to an intermediate state between 
paramagnetic and ferromagnetic, which means that these materials are magnetized 
when exposed to a magnetic field but they lose the magnetic properties once the 
magnetic field is removed. These materials are well-known by not having the so-called 
magnetic memory (Gupta and Gupta, 2005; Huber, 2005; Boyer et al., 2010; Dias et al., 
2011). Apart from its magnetic proprieties, MNPs are also biocompatible, easy to 
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synthesize and subsequently coat and functionalize. They also present unique 
versatility provided by the high surface area to volume ratio, which translates in high 
loading, and minimum diffusion limitations due to the fact of these materials being 
non-porous which reduces mass transfer limitations (Fang and Zhang, 2009; Boyer et 
al., 2010; Won et al., 2010; Dias et al., 2011). 
MNPs can be synthesized trough several methods, such as co-precipitation, thermal 
decomposition, microemulsion and hydrothermal synthesis, as summarized in Table 
1.1 (Lu et al., 2007; Laurent et al., 2008). 
Table 1.1 Summarized comparison of the different synthesis methods of Magnetic 
Nanoparticles (Adapted from Lu et al., 2007). 
The most common, efficient and easy method to synthesize magnetite is the co-
precipitation method which is based in the reaction between ferric and ferrous ions 
(in a molar ratio of 1:2) under basic conditions and oxygen-free environment (Equation 
1.1). The formation of the particles is firstly based in the formation of the crystalline 
nuclei (called as nucleation) when the medium is supersaturated, followed by crystal 
growth by diffusion of the solutes to the surface of the crystal (Gupta and Gupta, 2005; 
Laurent et al., 2008). 
                            (Equation 1.1) 
The main advantage of this method is the high quantity of particles that can be 
synthesized. The size distribution of MNPs is difficult to control as it only depends of 
kinetic factors. In order to control size, shape, properties and dispersibility of the 
MNPs several parameters (type of salt used, temperature, pH range, concentration, 
stirring rate) can be adjusted (Laurent et al., 2008; Wu et al., 2008). It has already been 
studied that the Fe2+/Fe3+ ratio and iron concentration are determinant factors in size, 
morphology and magnetic properties of MNPs in the co-precipitation method. A 
homogeneous core formation is obtained in presence of Fe2+/Fe3+ molar ratio close to 
Synthesis 
Method 
Reaction 
Temperature 
Size  
distribution 
Shape  
control 
Yield 
Co-precipitation 20 – 90 °C Relatively narrow Not good High / scalable 
Thermal 
decomposition 
100 – 320 °C Very narrow Very good High / scalable 
Microemulsion 20 – 50 °C Relatively narrow Good Low 
Hydrothermal 
Synthesis 
220 °C Very narrow Very good Medium 
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0.5, because the decrease of this ratio induces the appearance of an initial deposit and 
for values of this ratio above 0.6 the average particle size increases. The iron 
concentration is the second most relevant parameter with an optimum value between 
39 and 78 mM and an explanation similar to that of the Fe2+/Fe3+ ratio. These 
parameters combined with high pH, ionic strength and nitrogen bubbling contributes 
for the decrease of the size of the particles (Babes et al., 1999; Laurent et al., 2008). 
Despite the work that has been made to synthesize MNPs with higher quality, stability 
and dispersibility, it still continue to be one of the major problems (Gupta and Gupta, 
2005; Lu et al., 2007; Laurent et al., 2008; Dias et al., 2011). This low colloidal stability is 
associated with the highly active surface and with the high surface area to volume that 
creates a high energy on the surface of the particles and in order to diminish this 
energy, the particles tend to agglomerate. Both phenomena influence the size, shape 
and stability of the particles when in solution (Ditsch et al., 2005; Kuchibhatla et al., 
2005; Lu et al., 2007). Since the loss of stability has some drawbacks for the application 
of MNPs in certain areas, particularly those where MNPs are required in aqueous 
media, it is essential to develop strategies of stabilizing these particles. Different 
materials have been investigated to coat these particles and improve their properties 
(Gupta and Gupta, 2005; Lu et al., 2007; Dias et al., 2011). 
The coating of MNPs consists in the protection of the core structure with a layer 
through encapsulation or hydrophobic interactions, in order to isolate the core against 
harsh conditions, which improve biocompatibility of the particles and increase 
functionalization for further modifications (Lu et al., 2007; Fang and Zhang, 2009; Dias 
et al., 2011). The coatings most commonly used include: organic coatings such as 
surfactants and polymers or inorganic coatings as silica, carbon and precious metals 
(Lu et al., 2007). For the surface coating of MNPs different strategies can be applied, 
since in-situ coatings to post-synthesis coatings. In the last years the coating of MNPs 
with polymers, particularly biopolymers such as polysaccharides, attracted attention of 
researchers to be known to increasing biocompatibility, chemical functionality and 
colloidal stability of different materials, such as carbon nanotubes and silver and gold 
nanoparticles. However, these materials were also chosen because they are renewable, 
non-toxic and biodegradable which make them an environmental and sustainable 
choice (Dias et al., 2011). 
Polysaccharides are structures formed of repeating units (either mono- or 
disaccharides) interconnected by glycosidic bonds. These structures are often linear or 
branched (Dias et al., 2011). Some of the polysaccharides used for covering MNPs, 
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include agarose (Nixon et al., 1992), alginate (Ma et al., 2007), chitosan (Kievit et al., 
2009), starch (Kim et al., 2003), dextran (Hradil et al., 2007) and gum arabic (Roque et 
al., 2009). The biopolymers chosen to use in this work were Gum Arabic (Ga), Dextran 
(Dex) and Extracellular Polysaccharide (EPS). 
Gum Arabic is a natural gum taken from acacia tree steams. It is a negatively charged 
polysaccharide being mainly composed by 44% of galactose, 27% arabinose, 16% 
glucuronic acid, 13% rhamnose and 2-3% of peptide moieties. It finds applications in 
the food and pharmaceutical industries due to its excellent emulsifying properties and 
for the controlled release of actives and flavor compounds (Dias et al., 2011). 
Dextran a neutral polysaccharide is known for its several applications in the 
biomedical areas and to be the oldest polymer for coating MNPs. It is produced by 
certain lactic acid bacteria and it is mainly constituted of glucose molecules of several 
chain lengths and molecular weights (Dias et al., 2011). 
Finally, EPS which is also a negatively charged polysaccharide was used. This is a high 
molecular weight biopolymer mainly constituted by several neutral sugars as 
galactose, which is the most abundant monosaccharide, mannose, glucose and 
rhamnose and a small portion of acyl groups as pyruvil, succynil and aceyl. EPS is 
produced by a culture of gram-negative bacteria (Pseudomononas oleovorans) using 
glycerol as carbon source. But since this is a byproduct of biodiesel production it is 
available in high quantity and reduces the cost of production of this biopolymer 
making this polysaccharide a profitable choice for MNPs coating (Freitas et al., 2009). 
Biopolymers can also be used for increasing surface functionalization with promising 
active groups. Various biological molecules such as antibodies, targeting ligands and 
catalytically active species can modify the surface of these particles creating 
multifunctional supports with an enormous range of applicability, as explained below 
(Gupta and Gupta, 2005; Lu et al., 2007; Dias et al., 2011). 
1.2.2 Magnetic Nanoparticles and Their Applications 
The superparamagnetic properties of MNPs find interesting applications in the 
biomedical and biotechnological areas (Safarik and Safarikova, 2009; Dias et al., 2011). 
In the biomedical area, MNPs have tremendous potential in cancer treatment by 
hyperthermia, magnetic resonance imaging (MRI), cellular therapy and labeling, tissue 
engineering, gene and drug delivery (Dias et al., 2011). This preference is due to the 
superparamagnetic behavior that allows MNPs to be distal controlled or thermal 
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activated. It is also emphasized the relationship between the size of the particles and 
their movement in living organisms (Corchero and Villaverde, 2009; Dias et al., 2011). 
In terms of biotechnological applications, MNPs are applied in bioseparation 
processes, biosensing, biocatalysis, bioremediation and magnetofection (Dias et al., 
2011). The major benefits of using these particles in the biotechnological and 
bioengineering areas are the low-cost, speed, scalability and compatibility with 
complex biological suspensions (Batalha et al., 2010). 
Despite the several applications listed for MNPs the present work focus on MNPs 
applied to the biocatalysis and bioseparation fields. 
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1.3 Magnetic Nanoparticles for Biocatalysis 
Enzymes are extremely used in several industrial applications due to their unique 
properties, such as specificity, mild reaction conditions, biodegradability which 
translates into higher chemical precision and less side reactions. However, they have 
some problems associated to their use, such as short lifetimes, deactivation under 
harsh conditions and cost. The immobilization of enzymes, specifically in MNPs, 
brings a lot of advantages in the biocatalysts field. One of the main benefits is the 
potential for reusability and the easy recovery due to the magnetic proprieties of the 
solid support used (Kim et al., 2006). 
1.3.1 Production and Purification of Recombinant Proteins by tag 
Protein Fusion 
The market of recombinant proteins for biopharmaceutical applications has grown 
immensely and these proteins produced need to be highly purified and well 
characterized but at the same time economically profitable. Consequently, tag protein 
fusion became an essential tool to achieve the high standards required to implement 
these products and to reduce costs. 
A tag protein fusion system is a system based in the expression of a peptide fused with 
a protein of interest. Afterwards the tag protein fusion is purified in a 
chromatographic system against a specific affinity ligand for the tag (Waugh, 2005). 
Examples of tags commonly used are hexahistidine, maltose-binding protein, 
streptavidin, glutathione-S-transferase (Jenny et al., 2003). The major advantage of this 
system is the facile detection and purification of recombinant proteins by reducing the 
chromatographic steps needed to purify a protein, which becomes economically 
viable. Also, the insertion of a tag at the N-terminal position in an expression system is 
known to have influence in the production of the recombinant protein by improving 
protein yield, solubility and enhancing the correct folding of the protein (Hu et al., 
2001; Terpe, 2003; Waugh, 2005; Arnau et al., 2006; Gasparian et al., 2011). 
However, after the affinity-purification step it is crucial to remove the affinity tag. This 
step is essential according to the application for the purified product because the 
affinity tag might interfere with the structure or biological activity of the target 
protein. For the cleavage of the tag, a chemical treatment can be employed. In this 
method the reagents used are inexpensive, accessible and easily to scale-up. However, 
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denaturation of the proteins may occur due to the harsh conditions applied. 
Enzymatic cleavage is often preferred because of the higher selectivity and milder 
reaction conditions, which do not affect the structure of the protein. However soluble 
enzymes are costly and unstable. The most used protease enzymes are factor Xa, 
thrombin, tobacco etch virus (TEV) and enterokinase (EK) (Hu et al., 2001; Jonasson et 
al., 2002; Terpe, 2003; Waugh, 2005). 
EK is a very popular enzyme used for proteolytic cleavage, because it cleaves with high 
specificity after the sequence (Asp)4Lys, which allows the fusion protein to preserve its 
native amino-acid terminus without any additional unwanted cleavage amino-acid 
residues from the recognition sequence (Terpe, 2003; Bosse-Doenecke et al., 2008; 
Gasparian et al., 2011). 
Enterokinase is a membrane-bound protease of the intestine which controls an 
enzymatic cascade responsible by the intestinal digestion. This activation occurs 
through the recognition, cleavage and activation of trypsinogen by EK to yield active 
trypsin responsible for activation of pancreatic zymogens important in the digestion of 
food. This is a heterodimeric enzyme constituted by a heavy chain of 82-140 kDa that 
is disulfide linked to a C-terminal light chain of 35-62 kDa. The EK heavy chain is 
responsible to associate the enzyme to the membrane, whereas the light chain consists 
on the catalytic subunit (Light and Janska, 1989; Kitamoto et al., 1994; Lu et al., 1997; 
Lu et al., 1999). The binding site of this subunit consists of three main structural 
residues, Histidine 57, Asparagine 102 and Serine 195 and the catalytic activity of this 
enzyme is promoted by a divalent charge (Figure 1.1) (Lu et al., 1999). However, for the 
cleavage of fusion proteins, the recombinant catalytic subunit of EK alone has superior 
ability to cleave an artificial fusion protein containing the D4K recognition sequence 
(Lu et al., 1997; Gasparian et al., 2011). 
So far Enterokinase is known for the cleavage of fusion proteins mainly with 
therapeutic interest for cancer treatment including, mucin (Bäckström et al., 2003; 
Ditsch et al., 2005; Dziadek et al., 2005), deacetylases (Li et al., 2004), human growth 
hormones (Sturmfels et al., 2001) and cytokines (Wagner et al., 2005). 
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1.3.2 Magnetic Nanoparticles for Enzyme Immobilization 
The challenging demand for highly stable enzymes to be applied in several processes 
and products triggered the development of immobilized enzymes (Kim et al., 2006; 
Kubitzki et al., 2009). Through enzyme immobilization it is possible to reutilize the 
enzyme, which reduces the costs associated, and allows working in continuous mode. 
The environment of the enzyme is also more controlled which increases stability (Suh 
et al., 2005; Kubitzki et al., 2009). However, the immobilization process also leads to 
changes in the physical and chemical properties of the enzyme with consequent 
change in the activity of the immobilized enzyme. The main disadvantages of enzyme 
immobilization are related to the stereochemical and conformational effects, partition 
effects and the internal and external limitations to mass transfer (Buchholz et al., 
2005). Enzyme immobilization consists in the attachment of an enzyme into or onto 
modified surfaces through adsorption, covalent attachment or encapsulation. 
Depending on the support used the biocatalyst can have more or less efficiency (Kim 
et al., 2006). 
MNPs appear as an interesting alternative support for enzyme immobilization. These 
supports present a lot of advantages related to its properties and already proved to be 
efficient for the immobilization of some enzymes, as for the case of glucose oxidase 
used in blood glucose sensors (Rossi et al., 2004).  
For EK very few methods were developed for its immobilization (Table 1.2). EK has 
been immobilized on phospholipid vesicles and porous materials and some 
preliminary studies were also done in the immobilization of this enzyme in 
Figure 1.1 Representation of Enterokinase: A) Schematic representation of the structure of 
enterokinase (based on Light and Janska, 1989) and B) EK catalytic subunit structure with the 
residues of the catalytic center represented in dark red, representation obtained by the 
program PyMOL (code of pdb: 1ekb). 
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commercial paramagnetic microspheres. Due to the applications of this enzyme in 
recombinant protein production, it is important to continue developing better 
immobilization methods. 
Table 1.2 Known methods of Enterokinase immobilization onto specific support materials. 
Enzyme Support References 
Catalytic subunit EK 
Paramagnetic 
microspheres 
(Kubitzki et al., 2008) 
Catalytic subunit EK 
Hexamethylamino 
Sepabeads 
(Kubitzki et al., 2008) 
Catalytic subunit 
Recombinant EK 
Hexamethylamino 
Sepabeads 
(Kubitzki et al., 2009) 
Native EK Glyoxyl agarose (Suh et al., 2005) 
Purified bovine EK from 
duodenal mucosal cells 
Reconstituted Soybean 
phospholipid vesicles 
(Fonseca and Light, 1982; 
Fonseca and Light, 1983) 
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1.4 Magnetic Nanoparticles for Bioseparation 
The demand for high quality of therapeutic proteins but at the same time low cost 
associated therapies brought the need for exploring different types of separation 
techniques, in order to improve downstream processing known to be responsible for a 
significant percentage of the total manufacturing costs. MNPs appear as a viable 
choice for biotechnological industries, especially for the bioseparation processes since 
this option can overcome many problems, specifically cost reduction and process 
integration (Roque et al., 2004; Birch and Racher, 2006; Roque et al., 2007). 
1.4.1 Production of Antibodies 
Immunoglobulins, also known as antibodies, constitute approximately 20% of the 
plasma human proteins. These proteins are responsible for the response to foreign 
molecules or agents in the body to protect the organism against external aggressions 
and are produced by plasma B-cells as a response of the immune system (Roque et al., 
2004). 
Antibodies are conventionally represented as a Y-shaped structure, which is 
distinguished by two identical locations, the antigen-binding regions at the end of the 
Fab regions (fragment antigen binding) and one Fc (fragment crystallizable) region 
involved in effector functions. They are constituted by two identical heavy (H) chains 
of 50 kDa each, carrying covalently attached oligosaccharide groups; and two 
identical, non-glycosylated light (L) chains of 25 kDa each. The heavy chain and the 
light chain are linked together by a disulfide bond as well as the heavy chains. All the 
polypeptide chains contain constant regions (C) found at the carboxyl amino terminal, 
whereas at the amino terminal portions variable (V) regions are found and these 
regions are responsible for the affinity and specificity to the target molecules. The 
antibody structure is represented in Figure 1.2 (Roque et al., 2004). 
The success of antibodies as important therapeutic and diagnostic agents is related to 
the fact that they can bind to a diversity of antigens with high specificity, they present 
ability to conjugate antibodies with other therapeutic for efficient delivery of these 
agents to a specific target and also the reduction of side effects (Wang et al., 2007). 
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Protein engineering tools allowed the production of immunoglobulin fragments. One 
of the advantages of using antibodies fragments (Fab, Fc, Single-chain antibody 
Fragment (scFv)) are the capacity of entering more rapidly in certain targets and also 
to be cleared from the circulation more rapidly than full size antibodies which 
increases the applications in certain therapies such as tumor therapy (Marty et al., 
2001; Cunha et al., 2004; Wang et al., 2007). 
1.4.2 Purification of Antibodies through Affinity-Based Strategies 
For the in-vivo administration of the several forms of antibodies a very demanding 
production and purification is required by FDA (Food and Drugs Adminstration) in 
order to avoid contaminations of the therapeutic products and produce safe, pure and 
consistent products. However, besides the demand for more effective and robust 
strategies of production and purification, the industries have the challenge to reduce 
total manufacturing costs. The total costs of antibody production are incurred in the 
downstream processing which account for 50-80% of the total cost. So, in order to 
overcome these situations, purification strategies have to be designed to target high 
purity and yield product and minimum costs associated (Lowe et al., 2001; Roque et al., 
2007). 
The traditional antibody purification processes involved several steps such as an initial 
enrichment where water and main contaminants are eliminated by precipitation and 
filtration techniques, followed by the intermediary purification where 
chromatographic steps, such as ionic exchange separations, are mainly utilized. 
Finally, a polishing step to obtain high purity percentage (greater than 95%) are 
conducted frequently using gel filtration techniques (Roque et al., 2007). This 
Figure 1.2 Structure of an IgG molecule, where V 
represents the variable regions, C the constant regions and 
the domains of the light chain are represented by the L 
whereas for the heavy chain are represented by the H. 
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conventional purification process was substituted by affinity based methodologies 
(Lowe et al., 2001; Roque et al., 2007). 
Affinity based methodologies, are a suitable strategy to purify antibodies because they 
are based in a selective recognition strategy where the antibody molecule recognizes a 
specific complementary ligand. Since this binding is highly specific, the nonspecific 
interactions are reduced with increased yield and also there is elimination of several 
contaminants without requiring several steps to remove impurities. In the affinity 
based chromatography a ligand is covalently immobilized onto a solid support, 
commonly agarose or derivatives. Despite the advantages presented by the affinity 
methodologies the choice of the affinity ligand it is also important for the purification 
process. The affinity ligands mostly used to capture antibodies are biospecific ligands 
which are natural immunoglobulin binding ligands (Protein A, Protein L). However, 
these ligands are costly, labile and can leach under certain conditions. An alternative 
and promising choice is the use of synthetic affinity ligands, mimicking the biological 
ligands, which can be designed based in combination of molecular modeling tools and 
combinatorial synthesis. These synthetic ligands normally present lower affinity for 
antibodies but it is still possible to obtain high purity percentage of the products. 
These ligands are inexpensive, scalable, durable and present extraordinary stability 
under harsh conditions which improves purification processes of antibodies based on 
affinity methodologies. Examples of purification of antibodies by affinity 
methodologies using biological and synthetic affinity ligands are summarized in Table 
1.3 (Lowe et al., 2001; Labrou, 2003; Roco, 2004; Roque et al., 2007). 
Table 1.3 Purification of antibodies by affinity methodologies using biological and synthetic 
affinity ligands with purity percentage for each strategy. 
Type of Ligand Target Protein Ligand Purity Reference 
Biological Ligands 
Mab (mouse 
IgG2b) 
Protein A 98% 
(González et 
al., 2003) 
Bispecific 
diabody 
Protein L - 
(Kriangkum et 
al., 2000) 
scFv – Fc fusion 
protein 
Protein G - 
(Powers et al., 
2001) 
Biomimetic 
Ligand 
IgG, IgA, IgM Ligand 22/8 97 – 99 % 
(Teng et al., 
2000) 
IgG, Fab Ligand 8/7 90 – 95% 
(Roque et al., 
2005a; Roque 
et al., 2005b) 
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1.4.3 Magnetic Nanoparticles for Bioseparation Processes 
Affinity chromatography is the most widely used technique for antibody purification, 
but presents some limitations when using crude feeds related to the column operation 
and clogging of the packed bed adsorbents. This requires a clarification step before 
introduction of the sample in the column, which translates into increased costs and 
process complexity. One option that has been used to overcome these problems is the 
bed expanded system. However, this system also suffers limitations of low capacities 
due to the diffusion limitations and the short contact times for capture protein 
between the adsorbent beads and the proteins (Bucak et al., 2003; Roque et al., 2004; 
Ditsch et al., 2006; Roque et al., 2007). MNPs appear as a promising support for 
magnetic-based separations, since they present minimum diffusion limitations and 
permit rapid and easy removal of the functionalized MNPs from complex 
heterogeneous reaction mixtures, without being necessary previously filtration or 
centrifugation. In addition these supports are of easy manipulation which makes them 
a good choice for a downstream process (Figure 1.3) (Bucak et al., 2003; Roque et al., 
2004; Ditsch et al., 2006; Horák et al., 2007; Roque et al., 2007). 
In High Gradient Magnetic Separation (HGMS) once the product of interest is bound 
to MNPs, they are pumped into a separated column controlled by a magnetic field 
containing a filter. The first step of the separation process is based in switching on the 
magnetic field to retain the adsorbent, with the product of interest, while 
contaminates are eliminated. Subsequently fresh solutions of washing buffer enter the 
column and through cycles of switch on and off of the magnetic field the particles are 
resuspended and recollected from the washing buffer to eliminate unbound proteins. 
After washing the particles, the product recovery occurs through passing elution 
buffer with the magnetic field off to resuspending the particles. Finally, through action 
of the magnetic field the particles are recovered and the eluted product is purified 
(Hubbuch et al., 2001; Bucak et al., 2003; Ditsch et al., 2006; Franzreb et al., 2006). 
Figure 1.3 Schematic representation of a bioseparation process using MNPs as adsorbent. 
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1.5 Aim of the Work 
In this thesis, magnetic nanoparticles were explored as solid supports for biocatalysis 
and bioseparation. MNPs were synthesized with the purpose of producing controlled, 
stable and biocompatible particles by coating with three different biopolymers, Gum 
Arabic, Dextran and EPS (Figure 1.4). 
Specifically, when magnetic nanoparticles were applied for biocatalysis the enzyme 
Enterokinase was immobilized by two different chemistries, one based on the 
carboxylic groups available on the surface of the enzyme and other in the cysteine 
group available. For both immobilizations strategies the stability and activity of the 
immobilized enzyme was studied with a synthetic substrate and two fusions proteins. 
For the bioseparation field this work focus on modifying magnetic supports with a 
synthetic affinity ligand which mimics protein A, for the purification of antibodies 
from purified and unpurified mixtures. 
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Figure 1.4 Schematic representation of the research strategy followed in this work. 
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2 MATERIALS AND METHODS 
This chapter presents the materials and methods utilized to achieve the 
intended objectives.  In the first section all the chemical compounds, 
biochemical reagents, equipment and software used are described. In the 
second section the protocols performed to select and study the magnetic 
supports, immobilize the selected enzyme and the synthetic affinity ligand  are 
described and schematically represented.  
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2.1 Materials 
2.1.1 Chemical Compounds 
The reagents utilized were of the highest grade available. 
Glycine 98% (120072500), Hydroxylamine Hydrochloride 97% (17036100) were 
purchased from Acros. (3-Aminopropyl)triethoxysilane 99% (APTES) (44,014-0), 3-
hydroxyanilin (100242), 4-amino-1-naphtol hydrochloride 90% (133485), Cyanuric 
chloride 99% (S32029-066), N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) 
(39391), N-Hydroxysuccinimide (NHS) (S33678-046), Sodium Citrate Dihydrate ≥99% 
(W302600), Tris(Hydroxymethyl)amino methane (154563) were acquired from Aldrich. 
Glucose Monohydrate (5996-10-1) was from Fagron. Ammonium hydroxide (25%) 
(986030501), Ninhydrin > 99% (33437) were purchased from Fluka. 1,10-
phenanthroline 1-hydrate (131321), Ethanol Absolute PA (121086.1212 PA), Hydrochloric 
acid 37% (1310201211), Sodium Chloride (1316591211), Sodium-di-hydrogen Phosphate 1-
hydrate (1319651211), (Di) Sodium-hydrogen Phosphate 2-hydrate (12507.1211), Sodium 
Hydroxide (1316871211) were from Panreac. Calcium chloride dehydrate (31307) was 
from Ridel-de Haën. 2-propanol (9866.5), Acetone ≥ 99.5% (5025.5), Hydrochloric acid 
1 mol/L (K025.1), L-Cystein (1693,1) were purchased from Roth. 2-Naphtylamide 
(N8381), Dextran from Leuconostoc mesenteroides (D4876), Glutaric dialdehyde 50 
wt% sol in water (340855), Gly-Asp-Asp-Asp-Asp-Lys-β-naphtylamide (G5261), Gum 
arabic from acacia tree (G9752), HEPES (H3375), Iron (III) chloride hexahydrate 
(307718), Iron (II) chloride tetrahydrate (44939), Phenol (185450), Potassium Cyanide 
(60178), Pyridine > 99% (P57506), N,N-Dimethylformamide (319937) were acquired 
from Sigma. 4-(N-Maleimidomethyl)cyclohexane-1-carboxylic acid 3-sulfo-N-
hydroxysuccinimide ester sodium salt (Sulfo-SMCC) (M6035), Anthrone (319899), 
Ethylenediaminetetraacetic acid (ED) (EDTA), Sodium Bicarbonate (S6014), Sulfuric 
Acid (258105) were from Sigma – Aldrich. Nitrogen was provided by Air Liquide. The 
extracellular polysaccharide (EPS) was kindly provided by Prof.ª M.ª Reis from DQ, 
FCT-UNL. 
The protein quantification assay used was Bichinchoninic Acid (BCA) kit from Sigma. 
For the SDS-PAGE Gels the reagents used were: 30% Acrylamide /Bis Solution 37.5:1 
(161-0158), Sodium dodecyl sulphate Solution 10% (161-0416) purchased from BIO-RAD. 
Ammonium Persulphate (PSA) (9592.2), N,N,N,N – Tetramethylethylenediamine 
(TEMED) (2367.3), Bromphenol blue sodium salt (A5212.1) acquired from Roth. 
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Glycerol (G9012) purchased from Sigma – Aldrich. SDS Micropellets (Sodium dodecyl 
sulphate) (MB01501), Tris Base ultra-pure for Molecular Biology (MB01601), Glycine 
ultra-pure for Molecular biology (MB01401) were purchased from NzyTech. 2-
Mercaptoethanol (M6250) purchased from Aldrich. Hydrochloric acid 37% 
(concentrated) (1310201211) acquired from Panreac. 
To stain polyacrylamide gels the Silver Stain Plus Kit (161-0449) was used, which 
includes fixative enhancer concentrate (161-0461), silver complex solution (161-0462), 
reduction moderator solution (161-0463), image development reagent (161-0464) and 
development accelerator reagent (161-0448), from BIO-RAD. It was also necessary to 
use Methanol ≥ 99 % (8388.5) acquired from Roth and Acetic Acid Glacial (CAS 64-19-
7) purchased from Pronalab. 
2.1.2 Biochemical Reagents 
For the biocatalysis studies the Enterokinase and Cleavage Control Protein purchased 
from Novagen (69066-3) and a fusion protein expressed at the Biomolecular 
Engineering Group, FCT-UNL, were used. For the bioseparation studies the proteins 
tested were Human Normal Immunoglobulin (Gammanorm) from Octapharma 
(5044011), Albumin from bovine serum (A7906), from Sigma, and two different crude 
extracts kindly provided by Prof. Rui Oliveira from REQUIMTE, Portugal, and Dr. 
Paula Alves from ITQB, Portugal. 
The protein marker used in the SDS-PAGE was the Low Molecular Weight SDS Kit 
(NZYTECH) and Low Molecular Weight Precision Plus Protein Dual Xtra Standards 
(BIO-RAD). 
2.1.3 Equipment 
For the MNPs synthesis and chemical modification a mechanic stirrer from IKA, a 
water-bath SHC 2000 from Scanvac, a Sonicator SilverCrest and a centrifuge 
Scanspeed mini from Scanlav were utilized, whereas for the carbon coated MNP a GC 
6000 vega series 2 from Carlo ERBA instruments was used for the hydrothermal 
reaction at high temperature. 
Hydrodynamic diameter and Zeta Potential measurements of MNPs samples were 
performed in a Dynamic Light Scattering Zetasizer Nano ZS from Malvern (ITQB, 
UNL). 
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The enzymatic kinetic assays were performed in the incubator KS 4000 ic control from 
IKA, whereas the immobilization of the ligand 22/8 onto the magnetic supports was 
undertaken in the hybridization oven Boekel Big Shot IIITM from Bockel Scientific. 
For the adsorption isotherms of Dextran and hIgG onto MNPs a Digital Thermo Mixer 
Vortemp 56, S2056-A, from Labnet, was utilized. 
For the Anthrone and BCA Assays the reactions were incubated in the hybridization 
oven Boekel Big Shot IIITM from Bockel Scientific, while for the magnetite assay the 
pH of the reactions were adjusted in a microprocessor based Bench pH/ mV / °C 
meters from Hanna Instruments. 
All the spectrophotometric and spectrofluorometric measurements were taken with 
the Microplate Reader – Tecan Infinite F200 from Tecan. For the study of the GD4K-
2NA and 2-NA fluorimetric spectra a spectrophotometer PerkinElmer Lambda 35 
UV/Vi Spectrometer and a spectrofluorimeter PerkinElmer LS 45 Luminescence 
Spectrometer, were used. 
The Mini-Protean Tetra System from BIO-RAD was utilized for the electrophoresis 
SDS-PAGE gels. 
2.1.4 Kinetics and Screening Material 
The samples were analyzed in different types of microplates: for UV measurements, 
UV Star Plate 96 well Flat Bottom Half Area Greiner Bio-one were used; for 
colorimetric assays the Microplate 96 well Flat bottom Transparent Polystyrene 
(Starstedt) were utilized and in the fluorescence studies, BRAND Plates - Imunograde 
Tech Scientific were used. 
2.1.5 Software 
For the in silico analysis of enterokinase structural properties, it was utilized the 
PyMol 2009 DeLano Scientific LL. The illustrations were made using Marvin Sketch 
4.1.6 Pre1, from ChemAxon and ChemBioDraw Ultra 12.0, from CambridgeSoft. 
  
CHAPTER 2 - MATERIALS AND METHODS 
24 
 
2.2 Methods 
2.2.1 Selection and Study of Magnetic Supports 
In this work, the coating and modification of MNPs with three different biopolymers 
(Ga, Dex, EPS) has been studied. Therefore three different types of supports were 
produced: MNP coated with Gum Arabic (MNP_Ga); MNP coated with Dextran 
(MNP_Dex) and MNP coated with EPS (MNP_EPS), the protocols followed were 
identical for all supports. 
2.2.1.i Synthesis of Bare MNP and MNP coated with Biopolymers 
Bare MNP and MNP coated with biopolymers were synthesized by co-precipitation of 
FeCl3 and FeCl2 salts, using a Fe
2+/Fe3+ molar ratio of 0.5, through the addition of a 
base under inert atmosphere. The syntheses were performed at room temperature for 
the bare MNP and at different temperatures, depending on the biopolymer used for 
coating. 
A solution of 0.7 M ammonium hydroxide in deionized water was purged with N2 gas 
for 30 minutes in a closed reactor with mechanical stirring (1200 rpm). Then, a freshly 
prepared iron solution (5.4 g of FeCl3.6H2O and 2.0 g of FeCl2.4H2O in 25 ml of 
deionized water) was added dropwise to the ammonium hydroxide solution. For the 
coated magnetic nanoparticles an aqueous solution of the biopolymer selected was 
added dropwise to cover the bare MNP, the amount of biopolymer used and the 
temperature of reaction are described in Table 2.1. The reaction proceeded for two 
hours under an inert atmosphere. All the steps of the procedure were performed with 
agitation at approximately 1200 rpm and the pH was monitored and maintained at 10 
by addition of ammonium hydroxide solution. Finally, to eliminate the excess of 
ammonium hydroxide, the synthesized MNPs were washed several times with distilled 
water using a magnet for separation. 
Finally, in order to determine the concentration of the magnetic supports synthesized 
MNPs samples were dried overnight in the oven at 60°C. To quantify the amount of 
biopolymer bound onto the magnetic nanoparticles the amount of biopolymer in the 
washes, after in-situ coating strategy, were analyzed by anthrone method as described 
in section 2.2.4.ii. 
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Table 2.1 Strategies used to synthesize magnetic nanoparticles coated with different 
biopolymers. 
Biopolymer 
Quantity of 
Biopolymer used 
Biopolymer 
Solubility 
Temperature 
Gum Arabic 2.0 g 40 mg/mL 25°C 
Dextran 2.0 g 50 mg/mL 60°C 
EPS 0.3 g 10 mg/mL 25°C 
2.2.1.ii Stability to storage 
To determine the stability of the MNPs coated solutions to storage over time at 4°C, 
five washes with distilled water were performed at certain times. The supernatants of 
the washes were analyzed by the anthrone method (2.2.4.ii) in order to determine the 
quantity of biopolymer released. 
2.2.1.iii Adsorption isotherm of Dextran onto Magnetic Nanoparticles 
Solutions of bare MNPs (1 ml at 10 mg/mL) were washed six times with distilled water. 
Then, 1 mL of standard solutions of Dextran with concentrations between 0 and 85 
mg/mL were added. The mixtures were incubated 1 h at 60°C under orbital shaking. 
After incubation, the supernatants were collected and the amount of dextran released 
was quantified by the anthrone method as described in section 2.2.4.ii. 
2.2.1.iv Amination of the Magnetic Supports 
The different MNPs supports (10 mg/mL) were washed five times with deionized 
water. Afterwards an equal volume of deionized water was added and the suspension 
was sonicated for 30 minutes. After this step, a 3-aminopropyltriethoxy silane (APTES) 
solution was added dropwise to the suspensions to a final concentration of 10% (v/v), 
Figure 2.1. The samples were then incubated for 1 hour at 70°C in a water bath or oven. 
Finally, MNPs were washed 6 times, and sonicated again for 30 minutes. In order to 
quantify the amount of amines functionalized in each support a Kaiser Test was 
performed as described in section 2.2.4.i. 
Figure 2.1 Schematic representation of amination of magnetic nanoparticles with APTES. 
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2.2.1.v Stability of the Supports to Amination  
In order to determine the stability of MNP coated with biopolymers to amination, all 
the washes done after the amination step were analyzed by anthrone method (2.2.4.ii) 
to determine the quantity of biopolymer released. 
2.2.1.vi Synthesis of Carbon Coated Magnetic Nanoparticles 
Carbon Coated Magnetic Nanoparticles were synthesized by redispersing 20 mL at 10 
mg/mL of bare MNPs in a 0.5 M aqueous solution of glucose and sonicated for 10 
minutes. Then the suspension was transferred to an autoclave vessel and kept at 180 °C 
for 6 hours. In the end the particles were washed with distilled water six times and the 
MNP concentration was determined. 
2.2.1.vii Characterization of the Supports 
For all supports the physical properties (hydrodynamic diameters and zeta potential) 
were determined by Dynamic Light Scattering (DLS), using a Zetasizer Nano ZS from 
Malvern. For these analysis samples with a final concentration of 0.05 mg/mL in milli-
Q water were prepared. 
2.2.2 Immobilization of Enterokinase onto Magnetic Supports 
The magnetic nanoparticles previously coated by the three different biopolymers (Ga, 
Dex, EPS) were used as new carriers to immobilize an enzyme, Enterokinase, by two 
distinct chemistries as schematized in Figure 2.2.  
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2.2.2.i Immobilization of Enterokinase by EDC Coupling 
For the EDC coupling the enzyme was coupled on the surface of coated MNPs via 
carbodiimide activation by making use of the available carboxylic groups on the 
surface of the enzyme and the free amine groups at the surface of the particles. Each 
support (2 mL at 10 mg/mL with 5 µmoL of amines) was washed five times with PBS 
buffer (10 mM phosphate, 150 mM NaCl, pH 7.4) and in the end resuspended in 100 µL 
of PBS buffer. The EK carboxylic groups were activated by adding 6 U EK (1 µL), 5 
µmoL EDC (0.885 µL) and 1 mL PBS and this suspension was incubated for 15 minutes 
at room temperature with constant stirring. Afterwards the EK modified was added to 
100 µl of a magnetic support and the mixture was incubated overnight at 4 °C, with 
constant shaking. After that period the supernatant was collected and the supports 
were washed five times with 2 mL of PBS and finally resuspended in 2 mL of Tris-HCl 
buffer (50 mM NaCl, 20 mM Tris-HCl, 2 mM CaCl2.2H2O, pH 7.4). 
2.2.2.ii Immobilization of Enterokinase by Sulfo Coupling 
Alternatively, in the Sulfo Coupling Method Sulfo-SMCC was used as crosslinker to 
create stable maleimide-activated supports that reacted with sulfhydryls available on 
Figure 2.2 Schematic representation of EK Immobilization onto MNPs coated with Biopolymers 
(Gum Arabic, Dextran and EPS) by two different chemistries: A) EDC Coupling and B) Sulfo 
Coupling. 
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the enzyme. The aminated magnetic supports were activated by adding 10 µmoL of 
Sulfo-SMCC in 2 mL of PBS to the magnetic support at 10 mg/mL (5 µmoL amines). 
Then the mixture was incubated for 1 hour at room temperature with constant 
shaking. In the end the particles were washed five times with conjugation buffer (1 
mM EDTA, 0.1 M phosphate, 0.15M NaCl, pH 7.2) and resuspended in 1 mL of the same 
buffer. Afterwards, to perform the biomolecule coupling, 6 U of EK (1 µL) were added 
to the maleimide-activated support and incubated overnight at 4 °C with constant 
stirring. Finally the supports were washed five times with PBS and in order to block 
the remaining functional groups, the support with EK immobilized was incubated 1 
hour at 4 °C with constant shaking in the presence of a solution of 100 mM cysteine in 
PBS. To finish the immobilization process, the supports were washed five times with 
Tris-HCl buffer, pH 7.4 and resuspended in 2 mL of the same buffer for storage. 
2.2.2.iii Study of the Synthetic Substrate (GD4K – 2NA) and Product (2 - NA) 
The EK activity was studied by using a microplate fluorimetry activity assay with the 
synthetic substrate Gly-Asp-Asp-Asp-Asp-Lys-2-naphtylamide (GD4K – 2NA). The 
enzyme cleaved the substrate, releasing 2-naphtylamide (2-NA), a fluorophore that 
was monitored by spectrofluorimetry. 
To monitor the product released over time, it was necessary to determine the 
excitation and emission wavelengths of the fluorophore. To determine the excitation 
wavelength, several solutions of 2-NA with concentrations between 0.0005 mM and 
0.5 mM were prepared in Tris-HCl buffer, pH 7.4 (in order to dissolve the 2-NA 1% 
DMF was added) and absorbance was measured on a spectrophotometer PerkinElmer 
Lambda 35 UV/Vi Spectrometer. Consequently, for determining the emission 
wavelength solutions of 2-NA with concentration between 1x10-5 mM and 1x10-3 mM 
were also prepared in Tris-HCl buffer, pH 7.4 and analyzed in a spectrofluorimeter 
PerkinElmer LS 45 Luminescence Spectrometer by making use of the excitation 
wavelength determined before. 
After determining the excitation and emission wavelengths a calibration curve of 
standard solutions of 2-NA was confirmed on the microplate reader. All the 
measurements were performed at room temperature in a microplate with 150 µL of 
sample. 
To confirm if the method to quantify the 2-NA released is reliable a solution of 1 mM 
GD4K – 2NA was prepared and measured at the same emission and excitation 
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wavelength determined previously to confirm if the substrate influence on the chosen 
method. 
2.2.2.iv Quantification of EK immobilized on each support 
To quantify the amount of EK immobilized on each support, the supernatants 
recovered after each immobilization step were analyzed by enzymatic activity. The 
amount of product formed by the free enzyme that remains in the supernatants was 
analyzed. A calibration curve was determined with known concentrations of free EK 
with a correlation between the mol of 2-NA released (y-axis) and the µg of Free EK  (x-
values) with typical values of y = 3.0·10-8 x – 1·10-12. 
The reaction mixture contained 62.5 µL of the supernatant of each support with EK 
immobilized, 62.5 µL of Tris-HCl buffer pH 7.4 and 25 µl of 1 mM GD4K-2NA. As 
controls 62.5 µL PBS-EDC or Conjugation Buffer, 62.5 µL Tris-HCl and 25 µL 1 mM 
GD4K-2NA were used, depending on the chemistry used to immobilize EK. 
The reaction proceeded for 24 hours with constant stirring at 23 °C. The quantity of 
product released was measured in the microplate reader using an excitation filter of 
340 nm and an emission wavelength of 430 nm and a gain of 37 (samples of 150 µl were 
used in each well). 
2.2.2.v Kinetics assay of Free and Immobilized Enterokinase 
Free and Immobilized Enterokinase activity was determined fluorometrically using the 
synthetic substrate Gly-Asp-Asp-Asp-Asp-Lys-2-naphthylamide. The released 
fluorophore 2-naphthylamine was determined using an excitation filter of 340 nm and 
an emission wavelenght of 430 nm and a gain of 37 according to the calibration curve 
of the standard solution of 2-NA determined. The reaction mixture for Free EK 
contained 3U of Free EK, 500 µL of standard reaction buffer (Tris-HCl, pH 7.4) and 25 
µL GD4K-2NA 1 mM. For the activity of the immobilized EK was used 1 ml of the 2 mL 
of MNPs modified with EK resuspended with 500 µL of Tris-HCl, pH 7.4 and 25 µL of 1 
mM GD4K-2NA. 
Reactions proceeded for 24 hours with constant shaking at 23 °C covered with 
aluminum foil. At particular reaction times samples were taken and analyzed. Kinetics 
assays were repeated ten times for the immobilized EK, after each cycle the supports 
with immobilized EK were recovered and washed several times (5x times) with the 
standard reaction buffer (Tris-HCl, pH 7.4). 
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The controls were standard reaction buffer (Tris-HCl, pH 7.4) and each of the 
magnetic nanoparticles coated with each of the biopolymers resuspended in Tris-HCl, 
pH 7.4. Each of the controls were incubated with 25 µL of 1 mM GD4K-2NA and the 
reaction proceeded during 24 hours in the same conditions as the samples. 
2.2.2.vi Optimization of EK Immobilization 
After performing the kinetic assays with a synthetic substrate the best support of each 
chemistry (MNP_Dex) was selected to proceed with the studies. For the EDC Coupling 
the procedure in section 2.2.2.i was repeated but the particles were washed with, 1 M 
HEPES, 0.5 M NaCl, pH 8, and 5 µmoL NHS (0.0006 g) was added to the enzyme 
preparation. All the following steps were performed in the same conditions. For the 
Sulfo Coupling the protocol followed was performed as described on section 2.2.2.ii. 
After optimization of the EK immobilization on MNP_Dex, new five kinetic cycles 
were performed by making use of the synthetic substrate (GD4K-2NA) as previously 
described (2.2.2.v). This time after each cycle the supports with immobilized EK were 
recovered and washed ten times with the standard reaction buffer (Tris-HCl, pH 7.4). 
The MNP_Dex_EK by EDC Coupling has been selected as the best support, and tested 
with two different proteins containing a cleavage site recognized by Enterokinase. It is 
known that one unit is defined as the amount of enzyme that will cleave 50 µg of 
fusion protein in 16 hours at 23 °C, in a buffer containing 20 mM Tris-HCl pH 7.4, 50 
mM NaCl, 2 mM CaCl2 (supplier instructions). 
For Cleavage Control Protein from Novagen the reaction mixture contained 3 U of 
soluble EK and 10 µg of Cleavage Control Protein (Novagen) resuspended in 200 µl of 
standard reaction buffer (Tris-HCl, pH 7.4). For the activity of the immobilized EK, 1 
ml of MNP modified with EK was incubated with 10 µg of Cleavage Control Protein 
(Novagen) resuspended in 200 µl of Tris-HCl, pH 7.4 buffer. The reaction proceeded 
for 16 hours at 23 °C with constant shaking. 
For the fusion protein 180 µl of the protein (0.027 mg/ml) was reacted with 3 U of the 
soluble EK at Tris-HCl, pH 7.4 for 16 h at 23 °C. The immobilized EK was reacted at the 
same conditions as for Cleavage Control Protein from Novagen. 
For both cases the cleavage yield was determined by reading the SDS-PAGE gel. 
2.2.2.vii SDS-PAGE of the Protein Samples Tests 
After testing real protein with the soluble and immobilized enzyme the samples 
collected (Loading, Samples after digestion with Free EK and Immobilized EK) were 
CHAPTER 2 - MATERIALS AND METHODS 
31 
 
analyzed by gel electrophoresis 12.5 % Acrylamide/Bisacrilamide in denaturing 
conditions. The respective gels were prepared according to a standardized protocol, as 
presented in Table 2.2. 
Table 2.2 Necessary volumes to prepare two gels 12.5% of Acrilamide/Bisacrilamide. 
The Low Molecular Weight Marker and the samples were prepared by adding 2.5 and 
20 µL of each sample, respectively, and 5 µL of sample buffer (prepared with Solution 
II, 10 % SDS, β – mercaptoetanol, Glycerol and Bromphenol blue sodium salt) and 
were boiled for two minutes immediately before applying on the gel. The gels ran for 
80 minutes at 150 V and 250 mA by adding an electrophoresis Tris – Glicine Buffer 
(SDS-PAGE) diluted 10 times, prepared with 0.25 M Tris – Base, 1.92 M Glycine, 10 g 
SDS for 1000 mL of distilled water and pH adjusted at 8.3 with concentrated HCl. For 
detection of the protein bands, the gel was stained with Silver Stain Coloration kit. For 
this procedure, the two gels are placed for 20 minutes in a Fixative Enhancer Solution, 
prepared with 100 mL of Methanol, 20 mL of Acetic Acid, 20 mL of Fixative Enhancer 
Concentrate and 60 mL of Distilled Water, under gentle agitation. The Fixative 
Enhancer Solutions is removed, and the gels were rinsed in 200 mL of distilled water 
for 10 minutes with gentle agitation. After 10 minutes the water was decanted and 
replaced with fresh distilled water for an additional 10 minutes. For the Staining and 
Developing Step, a solution with 35 mL of distilled water and 5.0 mL Silver Complex 
Solution, 5.0 mL Reduction Moderator Solution and 5.0 mL Image development 
Reagent were mixed, immediately before use, with 50 mL of the Development 
Accelerator Solution (25 g Development Accelerator Reagent in 500 mL of high purity 
water) and quickly added to the gels. In this third step the gels were stained for 20 
Reagents 
12.5% Polyacrylamide Gel 
Running Gel Volume 
(mL) 
Stacking Gel Volume 
(mL) 
Solution I (3 M Tris-HCl, pH 
8.8) 
― 1.5 
Solution II (0.5 M Tris-HCl, 
pH 6.8) 
0.9 ― 
Solution III (Acrilamide – 
Bisacrilamide) (30:0.8) 
0.6 4.16 
10% SDS 0.036 0.1 
Distilled H2O 1.88 4.2 
PSA 10% 0.027 0.076 
TEMED 0.004 0.005 
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minutes with gentle agitation. Finally the gels were placed in a stop solution (5 % 
acetic acid solution) for 15 minutes. After stopping the reaction rinse the gels in high 
purity water for 5 minutes. The gels are then ready to be photographed. 
2.2.2.viii Characterization of the Supports 
Dynamic light scattering was used to determine the hydrodynamic diameter and the 
zeta potential of the various supports with EK immobilized. All the solutions were 
prepared as described on section 2.2.1.vii. 
2.2.3 Immobilization and Study of 22/8 onto Magnetic Supports 
The same supports of MNPs coated with Gum Arabic, Dextran and EPS were used to 
immobilize synthetic affinity ligands by three different methods as represented in 
Figure 2.3. These magnetic supports were then evaluated for protein purification. 
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Figure 2.3 Schematic representation of the Synthetic Affinity Ligand 22/8 Immobilized 
onto MNPs coated with Biopolymers (Gum Arabic, Dextran and EPS) by three different 
methods: Method A, Method B and Method C. 
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2.2.3.i Method A 
The ligand 22/8 with a six carbon space arm was previously synthesized in solution 
phase and purified, based on Teng et al., 2000. This compound was kindly prepared by 
Dr. Abid Hussain. 
The aminated particles (10 mg/mL) were washed five times with distilled water and 
finally resuspended in a solution of glutaraldehyde with a final concentration of 5% 
(v/v). Then the suspensions were first sonicated for 10 minutes and subsequently 
incubated for 1 hour at room temperature with constant shaking. After incubation the 
particles were washed five times with Milli-Q water. 
For the immobilization procedure (Figure 2.3 – Method A), magnetic nanoparticles 
modified with aldehyde groups (at 10 mg/mL) and respective controls (MNP_Ga, 
MNP_Dex and MNP_EPS), without any modification, were firstly washed five times 
with Milli-Q water. Then, the supports were incubated in a 1:1 stoichiometry (taking 
into account the number of amines of the support available) with the ligand 22/8 
previously dissolved in DMF:H2O (50:50) and centrifuged for 5 minutes at 13000 rpm 
to make sure the insoluble part was discarded. The incubation proceeded for 1 hour at 
room temperature at 300 rpm in an orbital shaker. Finally the particles were washed 
two times with DMF:H2O (50:50) and more five times with PBS and resuspended in 
PBS. The washes were collected in order to quantify the amount of ligand bound to 
the particles (by measurement of absorbance at 280 nm). However, it was not possible 
to quantify the amount of ligand bound due to problems with the solubilization step. 
Finally, in order to block the remaining functional groups the supports modified with 
ligand 22/8 by Method A were washed five times with distilled water and were 
incubated 1 hour at room temperature with constant shaking in the presence of a 
solution of 100 mM glycine in distilled water. 
2.2.3.ii Method B 
Ligand 22/8 was synthesized in solid phase and purified, according to Teng et al., 
2000, but this time it was synthesized without the six carbon spacer arm. This 
compound was kindly prepared by Telma Barroso. 
For this immobilization (Figure 2.3 – Method B), aminated magnetic nanoparticles at 
10 mg/mL, and respective controls (MNP_Ga, MNP_Dex and MNP_EPS), were initially 
washed five times with distilled water. Then were incubated with 5 molar equivalent 
(taking into account the number of amines available on the support) of ligand 22/8 
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dissolved in DMF:H2O (1:12) and with 1 equivalent of sodium bicarbonate. Incubation 
then proceeded for 2 days at 85 °C with constant shaking. Finally, the particles were 
washed two times with DMF:H2O (50:50) and more five times with distilled water and 
resuspended in water. The washes collected were measured spectrophotometrically at 
280 nm to quantify the amount of ligand bound to the particles. It was not also 
possible to quantify the amount of ligand bound to the particles. 
2.2.3.iii Method C 
Ligand 22/8 was synthesized directly on the particles based on the synthesis of 
triazine-based ligands (Figure 2.3 – Method C). The aminated supports were 
resuspended in 50% (v/v) Acetone/Water (MNP_Ga, MNP_Dex and MNP_EPS) and 
reacted with 5 molar equivalents (according to the amount of amines available on the 
support) of Cyanuric chloride, dissolved in acetone, during 2 hours at 0°C at 300 rpm. 
In the end of this reaction the magnetic nanoparticles were washed one time with 
acetone, one time with 50% (v/v) acetone/water and finally five times with water.  The 
first nucleophilic substitution on triazine ring was performed by adding 2 equivalents 
(relative to the amount of amines on the supports) of 3-hydroxyaniline in water. This 
reaction proceeded 24 hours with stirring at 30°C and after the reaction the particles 
were washed five times with water. Finally, for the second nucleophilic substitution, 5 
molar equivalents of 4 – amino – 1 – naphtol – hydrochloride, in the presence of 5 
equivalents of sodium hydroxide, dissolved in 50% (v/v) DMF/water, were added to 
the reaction and it was left to incubate for 48 hours with stirring at 90°C. The particles 
were then washed one time with 50% (v/v) DMF/water and more five times with 
water. Finally, the particles modified with ligand 22/8 were resuspended in water. All 
the washing procedures were based on the magnetic fishing properties of the supports. 
2.2.3.iv Assessment of hIgG and BSA binding to magnetic supports modified 
with affinity ligands 
The different carriers of magnetic nanoparticles modified with affinity ligand 22/8 (250 
µL at 6.0 mg/mL) were tested with a pure solution of hIgG, and with a pure solution of 
BSA for the best support chosen. 
The nanoparticles suspensions were washed with regeneration buffer (0.1 M NaOH in 
30% (v/v) isopropanol), followed by deionized water to neutralize the pH. These cycles 
of washes were repeated two times. Then the nanoparticles suspensions were 
equilibrated with binding buffer (50 mM phosphate, pH 8). After preparation of the 
supports the supernatants were removed and 250 µl of a hIgG or BSA solution in 
binding buffer (1 mg/mL) were added to the nanoparticles and incubated for 15 
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minutes at room temperature with constant stirring. The supernatant was then 
collected and the particles were washed five times with binding buffer (250 µL). Bound 
protein was eluted with a 50 mM Glycine – NaOH, pH 11 buffer. All samples were 
analyzed by the BCA assay (microplate reader assay), as described on section 2.2.4.iv, 
in order to quantify the amount of protein bound an eluted from the supports. For 
both assessments the non-modified particles (MNP and MNP_biopolymer) were tested 
at the same time and in the same conditions of the magnetic supports modified with 
affinity ligand. 
2.2.3.v Adsorption of hIgG binding to magnetic support 
Partition equilibrium experiments were performed with solutions of human IgG (0-18 
mg/mL; 250 µL) in phosphate buffer (50 mM, pH 8) and 250 µL at 6.1 mg/mL of 
MNP_Dex functionalized with ligand 22/8 by the Method C. The samples were 
incubated for 12 h at room temperature, after which the supernatants were collected 
and the amount of free protein quantified by the BCA protein assay as described on 
section 2.2.4.iv. The adsorption phenomenon followed Langmuir type isotherms 
(experimental data fitted with OriginLab 6.1) and was represented by 
   
        
      
                
In which q is the amount of bound protein in equilibrium per volume of solid support, 
Ceq is the concentration of bound protein in equilibrium,      corresponds to the 
maximum concentration of the matrix sites available to the partitioning solute (which 
can also be defined as the binding capacity of the adsorbent) and    the dissociation 
constant. 
2.2.3.vi Testing crude extract with magnetic supports 
After studying all the supports with a pure solution of hIgG, the best supports chosen 
were tested with two distinct crude extracts (kindly provided by Prof. Rui Oliveira, 
REQUIMTE, Portugal and Dr. Paula Alves, ITQB, Portugal) with the purpose of testing 
the specific and non-specific adsorption of contaminants on the magnetic supports. 
The functionalized (MNP_Dex_22/8 by the Method C) and non-functionalized 
supports (MNP_Dex) (500 µL with 54 mg/mL) were tested with 500 µL of each of the 
crude extracts, without any previously preparation, and incubated for 15 minutes at 4 
°C. For preparing the supports the procedure applied was the same as described at 
section 2.2.3.iv. Supernatants were collected and the particles were washed five times 
with binding buffer (500 µL). After washing, MNPs were divided and each 250 µL were 
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tested with an elution buffer, a 50 mM Glycine – HCl, pH 3 solution and a 50 mM 
Glycine – NaOH, pH 11 solution, respectively, in order to study the best elution 
conditions. 
All collected samples were analyzed by SDS-PAGE and stained with Silver Staining kit 
to confirm the bound and elution of the specific protein, but a BCA assay was also 
performed (microplate reader assay), as described on 2.2.4.iv, in order to quantify the 
amount of total protein in each of the samples collected. 
2.2.3.vii SDS-PAGE of the Crude Extract Test Samples 
After the Crude Extracts Tests the samples collected (Loading, Flowthrough, First 
three washes with Binding Buffer and First Two washes with each of the Elution 
Buffers) were analyzed by gel electrophoresis 12.5 % Acrylamide/Bisacrilamide in 
denaturing conditions. The respective gels were prepared according to a protocol 
standardized (2.2.2.vii section). 
Then the Low Molecular Weight Marker and the samples were prepared by adding 2.5 
and 10 µl of each sample, respectively, and 5 µl of sample buffer and boiled for two 
minutes immediately before applying on the gel. The gel ran for 80 minutes at 150 V 
and 250 mA by adding an electrophoresis Tris – Glicine Buffer (SDS-PAGE). For 
detection of the protein bands, the gel was stained with Silver Stain Coloration kit. All 
the buffers and gel preparations were performed as described on section 2.2.2.vii. 
2.2.3.viii Characterization of best Method to modified Magnetic Supports 
with affinity ligands 
Dynamic light scattering was used to determine the hydrodynamic diameter and the 
zeta potential of the various supports immobilized with the ligand 22/8 by the Method 
C. All the solutions were prepared as described on section 2.2.1.vii. 
2.2.4 Quantification Methods 
2.2.4.i Quantification of the Amine content by Kaiser Test 
The quantity of amines functionalized in each support was determined by the Kaiser 
Test. This is a qualitative test based on the reaction of ninhydrin with primary amines, 
as schematized in Figure 2.4, which gives a characteristic dark blue colour. To the 
aminated magnetic nanoparticles support (10 mg of particles to a total volume of 1 ml) 
were added 50 µL of each of the following reagents: 80% crystalline phenol in ethanol 
(w/v), 2% 0.001 M aqueous solution of potassium cyanide in pyridine (v/v) and 5% 
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ninhydrin in ethanol (w/v). The samples were then incubated in a water-bath at 100°C 
for 5 min. The calibration curve was performed with standard solutions of glycine (0-5 
µmoL/mL) and the absorbance measurements of the samples (diluted 1:16) were 
performed at 560 nm. The calibration curve of the Kaiser test has typical values of y = 
4.057x – 0.1354, with a correlation factor of R2 = 0.9961, where the y-axis represented 
the absorbance at 560 nm and the x-axis the concentration of glycine in µmoL/mL. 
2.2.4.ii Quantification of Saccharides by Anthrone Method 
This is a colorimetric assay where the anthrone reagent in sulfuric acid allows 
determining saccharides, as demonstrated in Figure 2.5. To perform this assay 110 µL of 
sample were mixed with 220 µL of digestion reagent, which is prepared by adding 5 
mL of 67% Sulfuric acid to 6.25 mg of anthrone. Then the reaction is incubated during 
14 minutes at 100°C. Finally, the samples are left to cool and the product formed is 
read at the wavelength of 600 nm by using 200 µL of sample in each well of the 
microplate. The calibration curve was performed with standard solutions of the 
biopolymer under analyses (0 – 0.5 mg/mL). The values of the calibration curve 
obtained depend on the biopolymer used, for Gum Arabic the typical values were y = 
5.676x – 0.0044 (R2 = 0.9987), for the Dextran the typical values were y = 5.4112x – 
0.0229 (R2 = 0.9918) and finally for the EPS the typical values were y = 3.8371x + 0.0011 
(R2 = 0.9983). 
Figure 2.4 Schematic representation of the chemistry of Kaiser Test 
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2.2.4.iii Quantification of Iron content by Magnetite Assay 
The amount of iron released during the pH resistance assays were determined by the 
magnetite assay which is based on ferrous ion formed. The principle of this 
colorimetric assay relies on the formation of ferric ions by magnetite under acidic 
conditions. The ferric ions were reduced to ferrous ions by the presence of the 
hydroxylamine hydrochloride. Then, three molecules of 1,10 – phenantroline react with 
Fe2+ ion, forming a characteristic orange-red colored complex that absorbs light at 509 
nm. The intensity of the color formed is directly proportional to the amount of Fe2+ in 
the sample (Magnetite Assay schematized in Figure 2.6). 
During the magnetite assay to the 100 µL of each sample 0.5 ml of concentrated HCl 
followed of 0.5 ml of 1.44 M hydroxylamine hydrochloride solution were added. After 
15 minutes, 1 ml of 0.0126 M ο-phenantroline solution was added, the mixture was then 
neutralized with 0.25 mL of 12 M NaOH. Finally, the pH was adjusted to about 4.0 
through the addition of 0.5 M sodium citrate buffer. The absorbance was read at 492 
nm in a microplate reader (by using 200 µL of sample in each well). To quantify the 
amount of iron released in the assay was used a calibration curve from 2.44x10-3 to 2.5 
mg/ml of Bare MNP. The typical values of calibration curve obtained for this assay are 
y = 0.5095x + 0.0072 with a correlation factor of R2 = 0.9949. 
Figure 2.5 Schematic representation of the chemistry of Anthrone Method. 
Figure 2.6 Schematic representation of the chemistry of the Magnetite Method. 
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2.2.4.iv Quantification of Protein content by BCA Assay 
In order to quantify the amount of total protein the BCA Method (Bincinchoninic acid 
- Figure 2.7) was employed. This colorimetric method has the advantage of being a 
more sensitive method and easy-to-use method when compared with Lowry Assay. 
This method relies on the formation of a complex Cu2+-Protein under alkaline 
conditions, followed by the reduction of copper (Cu2+   Cu+). On a second step the 
monocation formed reacts with two molecules of bicinchoninic acid and forms a 
purple solution which absorbs light at any wavelength between 550 – 570 nm. The 
magnitude of absorbance is directly related to the amount of protein existent due to 
the proportionality between the degree of reduction of Cu2+ and the protein content. 
To perform the BCA assay 25 µL of sample (samples collected in the loading, washes 
and elution obtained in the assessment of protein binding to magnetic supports) were 
added in each well of a 96-well microplate. The BCA reagent was prepared by adding 
50 parts of reagent A (BCA Solution, sodium carbonate, sodium tartrate and sodium 
bicarbonate in 0.1 N NaOH at pH 11.25) and 1 part of reagent B (Copper (II) Sulfate 
Pentahydrate 4% Solution). Then, 200 µL of BCA working reagent was added in all the 
wells and the microplate was incubated in the dark at 37 °C for 30 minutes. Finally, the 
absorbance was measured at 560 nm in the microplate reader. To determine the 
amount of Total Protein in the different assays was used a calibration curve from 0 to 1 
mg/mL of hIgG (y = 1.4607x + 0.0438, R2 = 0.9901) or BSA protein (y = 1.203x + 0.0346, 
R2 = 0.9938) depending on the assay performed. 
Figure 2.7 Schematic representation of the chemistry of the BCA Method to protein 
quantification. 
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3 SELECTION AND STUDY OF 
MAGNETIC SUPPORTS 
This chapter presents the work developed towards the study and selection of 
magnetic supports for further applications in biocatalysis and bio separation 
fields. The results of the synthesis, stability and characterization of magnetic 
nanoparticles coated with three different biopolymers – Gum Arabic, Dextran 
and Extracellular Polysaccharide are presented. 
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3.1 Introduction 
The synthesis of materials at the nanoscale has experienced a tremendous growth in 
the last decade and it is possible to observe a huge interest in their use in 
technological and biomedical applications (West and Halas, 2000; Liu, 2006). The 
great interest in nanoparticles is related to the fact that these new materials have 
similar dimensions to biomolecules which enables a better integration with biological 
systems (West and Halas, 2000; De et al., 2008). 
Thus, nanoparticles became a highly attractive new platform for biotechnological 
applications mostly due to their new and unique physical and chemical properties 
obtained from the different materials and size. There has been an intense search for 
methods of synthesis with an extreme control on the size and morphology of the 
nanoparticles (West and Halas, 2000; Liu, 2006; De et al., 2008). This growing interest 
lies in the fact that there is a strong dependence between the dimensions and 
properties of the nanomaterials. 
Nanoparticles of several materials have been studied, however there has been given a 
considerable emphasis to MNPs because of the size, large surface area and 
superparamagnetic properties (Gupta and Gupta, 2005). However, these particles 
reveal several problems related to the colloidal stability, once they tend to form 
agglomerates associated to the high surface area to volume ratio. Besides that, the 
chemistry of the bare MNPs is highly active which makes them easily oxidized and 
subsequently susceptible of losing magnetism and dispersibility (Gupta and Gupta, 
2005; Liu, 2006; Dias et al., 2011). 
Since the size, morphology and colloidal stability are the most important features for 
most of the applications (Gupta and Gupta, 2005; Laurent et al., 2008), there is an 
indispensable need of developing strategies to fabricate and protect the MNPs in order 
to stabilize and obtain robust nanoparticles which can endure the necessary 
conditions to a certain application (Lu et al., 2007). 
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3.2 Results and Discussion 
3.2.1 Synthesis and Modification of Magnetic Supports 
For the synthesis of the magnetic supports the method applied was the chemical co-
precipitation technique of iron salts based on previous works (Batalha et al., 2010). 
This method is simple and with well determined conditions the quality of the MNPs 
are entirely reproducible. Through this method it was possible to synthesized iron 
oxide particles with superparamagnetic properties, as shown in Figure 3.1. 
Due to the inherent instability of these materials (Gupta and Gupta, 2005; Lu et al., 
2007; Dias et al., 2011), the surface was coated with three different biopolymers, Gum 
Arabic, Dextran and Extracellular Polysaccharide by making use of the in-situ coating 
strategy. These polysaccharides were chosen as agents for the surface modification of 
these carriers since they were found to be colloidal stabilizers, mediators for increase 
biocompatibility and for introducing several functional groups on the support surface. 
Besides that, they are renewable materials, produced from other biological compounds 
and they are non-toxic and biodegradable (Dias et al., 2011). For the production of 
these materials a diversity of parameters can be adjusted in the synthesis to control 
the characteristics and properties of the supports (Laurent et al., 2008). For the 
specific case of the supports synthesized the conditions applied, Table 3.1, were 
suggested according to previous works already studied and to the binding profiles of 
the biopolymers at the surface of bare MNP (Hong et al., 2008; Batalha et al., 2010; 
Marcos, 2010). 
Figure 3.1 Representation of the superparamagnetic properties of MNPs in the present of an 
external magnetic field. 
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Table 3.1 Parameters adjusted for the synthesis of MNP coated with Gum Arabic, Dextran and 
EPS by the co-precipitation method according to Roque et al., 2009; Marcos, 2010. 
For the MNP coated with Gum Arabic, the synthesis was based on previous works 
(Batalha et al., 2010) but the amount of Ga added to the reaction was adjusted 
according to the binding profiles of Ga previously studied (Roque et al., 2009). 
According to Roque and co-workers the formation of the Gum Arabic monolayer onto 
bare MNP follows a Langmuir profile with an optimum value of 1.04 g Ga adsorbed/g 
MNP (Roque et al., 2009). Considering this value, and taking into account that in each 
synthesis 2 g of MNP are produced, 2 g of Gum Arabic dissolved in water were added 
during MNPs synthesis, as described in section 2.2.1.i. 
The quantity of Ga adsorbed onto bare magnetite by the in-situ co-precipitation 
strategy was then confirmed by the anthrone method, as described in section 2.2.4.ii. 
By this method it was estimated that 0.80 g Ga adsorbed/g MNP were adsorbed. This 
value is slightly lower than the maximum adsorption profile (1.04 g/g) but this 
difference is probably due to the sensitivity of the quantification method used, to the 
heterogeneity of the MNP or GA samples and also due to the difference between the 
synthesis performed and the conditions followed for the adsorption isotherm, where 
adsorption of Ga onto the MNPs is performed after the synthesis of the particles. It is 
believed that the carboxyl groups of Ga, mainly from the glucuronic acid, react with 
the surface hydroxyl-groups of the particles and the amine groups, mainly in the 
peptide moieties, interact with iron oxide surface to form hydrogen-bonds (JianHan et 
al., 2007; Roque and Wilson Jr, 2008). 
Regarding the synthesis of MNP coated with Dextran the protocol followed was based 
on the works of Hong et al., 2008; Batalha et al., 2010. For this protocol the 
temperature of the reaction was set to 60 °C, since according to some previous studies 
the reaction temperature increased the adsorption of dextran onto magnetite surface. 
This parameter is also responsible for decreasing the average diameter of the 
nanoparticles which has direct influence in reducing the problems related to 
agglomeration of the particles (Xu et al., 2005; Hong et al., 2008; Zhao et al., 2008). In 
terms of the quantity of dextran used in the synthesis, this parameter was selected 
Biopolymer 
Coating 
Biopolymer 
used 
Biopolymer 
Solubility 
Temperature 
Biopolymer 
Adsorbed (g) 
/ MNP (g) 
Qmax [Biop. 
Adsorbed (g) 
/ MNP (g)] 
Gum Arabic 2.0 g  40 mg/mL 25°C  0.80 1.04 ± 0.07 
Dextran 2.0 g  50 mg/mL 60°C  0.88 1.3 ± 0.1 
EPS 0.3 g  10 mg/mL 25°C  0.14 0.9 
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according to the binding profile of Dextran at the bare MNPs surface as determined in 
Figure 3.2 – A and B. 
By the results of the adsorption isotherm of Dextran, quantified by the anthrone 
method, it was possible to fit the results for low dextran concentration with a 
Langmuir model with a correlation factor of 0.97, a dissociation constant of 2.3 ± 0.8 
mg Dex adsorbed/mL and with an estimated maximum of 1.3 ± 0.1 g Dex adsorbed/g 
MNP. This fitting gave the value at which the MNPs surface becomes saturated after 
the formation of a biopolymer monolayer. For this case, the adsorption mechanism is 
probably attributed to Van der Waals forces, electrostatic interactions and mostly to 
hydrogen bonds which have often been involved in the interaction between neutral 
polysaccharides and mineral surfaces (Li and Spencer, 1992; Hong et al., 2008), 
because dextran is composed by glucose molecules of varying chain lengths being rich 
in hydroxyl groups. 
The biopolymer seems to form multiple layers around MNPs. After the formation of 
the first monolayer, the amount of Dextran adsorbed increased for higher 
concentration of Dextran in solution (Figure 3.2 – A). An attempt was made to fit the 
total data points from Figure 3.2 – A using other adsorption isotherms models 
Figure 3.2 Binding profile of Dextran at the surface of bare iron magnetic nanoparticles: A) 
Binding profile of different solutions of dextran with different concentrations and B) Binding 
profile of low dextran concentration at the surface of bare iron magnetic nanoparticles. 
Representation of q (the amount of bound Dextran in equilibrium per mass of solid support) as 
function of Ceq (the concentration of Dextran in equilibrium). Experimental data was fitted 
with the expression q = (Qmax × Ceq)/(Kd + Ceq) for the Lagmuir isotherm (using the OriginLab 
6.1 software), where Qmax corresponds to the maxium concentration of the matrix sites available 
to the partitioning solute (which can also be defined as the binding capacity of the adsorbent), 
and Kd is the dissociation constant. 
1st Monolayer 
A)
) 
B) 
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available, but with no success. Probably there are not enough points that define the 
second or more adsorption layers. Assuming the formation of a first monolayer, these 
results were kept to define the amount of dextran to coat the MNPs. 
Finally, for the MNP coated with EPS the amount of biopolymer added during the 
MNPs formation was 0.3 g due to the poor solubility in water (Table 2.1). Previous 
works indicate that the adsorption isotherm of EPS on MNPs do not follow a perfect 
Langmuir model but a maximum of EPS adsorbed per gram of MNPs was estimated 
around 0.9 g EPS adsorbed/g MNP (Marcos, 2010). Therefore the quantity of EPS 
added to the reaction fell far short from the optimal amount necessary for the 
formation of a biopolymer monolayer. Still, almost 47% of the biopolymer (0.14 g EPS 
adsorbed/g MNP), added in the beginning of the reaction, adsorbed to the surface of 
the MNPs. However, it is important to keep in mind that the adsorption isotherm is 
performed in conditions slightly different from the synthesis of the particles because 
the biopolymer is added after the MNPs formation. With these results it is possible to 
predict that 84% of the support is not properly coated with the biopolymer and part of 
the magnetite core is exposed making this support extremely reactive. The adsorption 
of EPS to MNPs is most likely mediated between the hydroxyl groups present on 
MNPs and on the polymer, mainly in the galactose groups which are the major 
constituent of this polymer. However, this biopolymer also establishes some bonds 
between the carboxyl groups, available in the small percentage of acyl groups of this 
polymer, and the hydroxyl groups present in the surface of the MNPs. 
In conclusion, it was possible to coat magnetite particles with the three biopolymers 
selected to increase colloidal stability and reduce nonspecific adsorption effects. In the 
case of the MNPs coated with Ga and Dex were bound 80% and 90%, respectively, of 
each biopolymer to the surface of MNPs. For the case of the MNPs covered with EPS 
to improve the coating with this polymer, the synthesis strategy should be optimized 
in terms of the quantity of biopolymer added in the beginning of the synthesis of this 
support. 
MNPs were successfully coated with the three different biopolymers, but the efficiency 
of a support in a certain area of application also depends on the binding specificity of 
the support (Gupta and Gupta, 2005; Laurent et al., 2008; Dias et al., 2011). This 
specificity is acquired through the introduction of biological molecules or specific 
receptors on the surface of the carriers (Gupta and Gupta, 2005; Dias et al., 2011). One 
common step for the modification of magnetite particles is the amino-silanization, a 
method that produces covalently bound amino groups on the surface of the supports 
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through the use of the free hydroxyl groups at the particles surface, Figure 2.1 (Wu et 
al., 2008). This step is also crucial since the introduction of the aminopropyltriethoxy 
silane groups can work as spacer arm between the immobilized biomolecules and the 
supports. In this work all, the biopolymer coated supports were modified with 
aminopropyltriethoxy silane, as described in section 2.2.1.iv (Table 3.2). 
Table 3.2 Degre of amination of the magnetic supports synthesized, values measured by the 
Kaiser test (n = 4). 
3.2.2 Stability of Magnetic Supports 
The preparation of a magnetic support should meet the conditions required for its 
application. It is important to assess the support’s stability towards storage, chemical 
modification, pH and oxidation (Gupta and Gupta, 2005; Laurent et al., 2008). 
In the present work, the stability of the supports towards storage (Figure 3.3) and 
modification with amino-silane (Figure 3.4) was assessed. Also a preliminary study was 
performed to optimize the pH resistance of the supports. 
Data indicates that the amount of biopolymer bound to MNPs is very stable to storage 
and chemical modification with APTES. 
MNP Samples µmol NH2 / g MNP 
Gum Arabic 189 ± 18 
Dextran 214 ± 44 
EPS 196 ± 8 
0 
0,1 
0,2 
0,3 
0,4 
0,5 
0,6 
0,7 
0,8 
0,9 
1 
0 50 100 150 200 
g
 B
io
p
o
ly
m
e
r 
B
o
u
n
d
 /
 g
 S
u
p
p
o
rt
 
Time (Days) 
MNP coated GA MNP coated Dex MNP coated EPS 
Figure 3.3 Storage stability of the synthesized supports along the 
time, values determined by the anthrone method. 
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The magnetite particles tend to oxidize to maghemite at high temperatures (80 °C) 
and dissolve under acidic conditions (Batalha et al., 2010). In particular the low 
resistance to acidic pH can decrease the range of applications of these MNPs. A 
preliminary study was conducted with a carbon coating of the magnetite particles. 
This coating method, schematized in Figure 3.5, consists on the formation of carbon 
nanospheres through the aromatization and carbonization of glucose under 
hydrothermal conditions, where iron oxide nanoparticles are the nuclei for the 
formation of the carbon composites (Sun and Li, 2004; Wang et al., 2006; Qi et al., 
2009). Through this chemical modification of glucose a large number of functional 
groups as hydroxyl groups appear at the surface of the support. Previous reports 
indicate that this carbon-layer increases thermal stability, high stability against 
oxidation and acidic leaching, and also provide an active surface for covalent 
attachment of biomolecules (Sun and Li, 2004; Lu et al., 2007). 
0 
100 
200 
300 
400 
500 
600 
700 
800 
900 
1000 
Before Amination After Amination 
m
g
 B
io
p
o
ly
m
e
r 
B
o
u
n
d
 /
 g
 S
u
p
p
o
rt
 
MNP_Ga MNP_Dex MNP_EPS 
Figure 3.5 Schematic representation of the synthesis of the carbon coating magnetic 
nanoparticles based on Sun and Li, 2004; Qi et al., 2009. 
Figure 3.4 Chemical modification stability of the synthesized 
supports, values determined by the anthrone method 
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After the synthesis of the carbon coated nanoparticles, this support was tested with 
different pH solutions in order to quantify the amount of magnetite released to the 
solution, as described in section 2.2.4.iii (Figure 3.6). It is possible to observe that 
carbon coated particles are more resistant to pH 3 when compared with the bare 
MNPs, as described in literature (Sun and Li, 2004; Lu et al., 2007). However, at 
neutral and basic pHs the carbon coated particles seem to lose stability which is 
confirmed by an increase in magnetite in solution. It was not possible to find literature 
to support these results. On the other hand the magnetite method utilized is less 
sensitive than ICP-AES, as shown in Batalha et al., 2010 where at pH 11 magnetite was 
released from bare MNP. 
 
3.2.3 Characterization of Magnetic Supports 
The Dynamic Light Scattering Zetasizer Nano ZS from Malvern (DLS) measures the 
hydrodynamic diameter, analyzed in Figure 3.7 and Table 3.3 and the zeta potential, 
Figure 3.8, of the MNPs. 
The coating of the particles with different biopolymers leads to an increase of the 
hydrodynamic diameter of the particles for values between 1500 – 3000 nm. The 
formation of larger agglomerates when the particles were coated has already been 
observed in other works (Williams et al., 2006; Wilson Jr et al., 2008; Batalha et al., 
2010). One should bear in mind that the diameter of each individual magnetic core is 
around 10-12 nm (Batalha et al., 2010). This might be explained by the non-covalent 
interactions between the coating biopolymers of neighbor nanoparticles. It is also 
interesting to observe the slight decrease of the hydrodynamic diameter for the 
MNP_Ga and MNP_EPS and an increase of the hydrodynamic diameter for the 
MNP_Dex when the supports are aminated, however the errors associated are too 
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Figure 3.6 Quantity of iron released from bare MNPs and carbon 
coated MNPs at different pHs (n = 2). 
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high. For the Carbon Coated MNPs, the hydrodynamic diameter is around 1000 nm 
and here it is also possible to conclude the presence of some agglomeration of the 
particles. 
According to Table 3.3 it is possible to conclude that the supports synthesized are not 
uniform in size and present a high polydispersitivity with values between 0.6 and 1, 
which is corroborated by the higher error bars determined and through the aggregates 
that are big enough to be seen by naked eye, which means that this values are not 
reliable and a different method should be used to analyze this parameter. This can be 
explained by the fact that DLS is a good technique for measure particles with size 
smaller than 1 µm. Since the particles synthesized present sizes in the magnitude order 
of 1 to 2 µm the technique used has no sensibility to perform a good measurement 
hence present values of polydispersit so high. In order to determine the size of the 
particles synthesized should be chosen a different technique, such as Mastersizer also 
from Malvern. This is a technique with a higher measuring range (0.02 µm – 2000 µm) 
that is more appropriate for the particles that were synthesized. 
Table 3.3 Hydrodynamic Diameter and Polydispersitivity values for magnetic nanoparticles (n 
= 2). 
 
  
MNP Supports 
Hydrodynamic 
Diameter (nm) 
PDl 
Bare MNP 568 ± 37 1.0 ± 0.0 
MNP_Ga 1650 ± 234 0.77 ± 0.02 
MNP_Dex 1526 ± 638 0.76 ± 0.04 
MNP_EPS 2919 ± 409 0.79 ± 0.02 
Carbon Coating MNP 1080 ± 159 0.67 ± 0.18 
MNP_Ga_NH2 1093 ± 64 0.61 ± 0.06 
MNP_Dex_NH2 3506 ± 1078 0.80 ± 0.38 
MNP_EPS_NH2 2403 ± 309 1.0 ± 0.0 
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The majority of the particles dispersed in an aqueous solution will have a charged 
surface either by ionization of surface groups or adsorption of charged species. This 
will modify the distribution and will increase the concentration of the surrounding 
ions. The liquid layer surrounding the particle exists as two parts; an inner region 
(Stern layer) where the ions are strongly bound and an outer (Diffuse layer) region 
where they are less firmly connected. Within the diffuse layer there is a notional 
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Figure 3.7 Hydrodynamic diameter (nm) of the magnetic supports by 
dynamic light scattering analysis (n = 2). 
Figure 3.8 Zeta Potential values (mV) at pH 7 for magnetic supports by 
dynamic light scattering analysis (n = 2). 
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boundary inside which the ions and particles form a stable entity. When a particle 
moves (e.g. due to the voltage that is applied), ions within the boundary move it. 
Those ions beyond the boundary stay with the bulk dispersant. This boundary is called 
slipping plane. The potential that exists at this boundary is called the zeta potential. 
The magnitude of the zeta potential gives an indication of the potential stability of the 
colloidal system. Particles in suspension with a high zeta potential of the same charge 
tend to repel each other and resist aggregation. However, if the particles have low zeta 
potential values then there will be no force to prevent the particles coming together 
and flocculating. It is conventionally assumed that high zeta potential values are 
below -30 mV or above +30 mV. This means that particles with zeta potentials more 
positive than +30 mV or more negative than -30 mV are normally considered stable. 
Through Figure 3.8 bare MNP have a zeta potential of -20 mV, this potential is 
attributed to the oxygen groups available in the tetrahedrally - octahedrally structure. 
When particles are coated with the different polymers the global charge is altered 
according to the type of biopolymer used. For the MNP coated with Gum Arabic, 
Batalha and co-workers concluded that the zeta potential value of Ga in suspension is 
-16.45 mV (Batalha et al., 2010). For the particles synthesized in this work it is possible 
to conclude that the particles are well coated because the zeta potential of MNP_Ga is 
in the same order of magnitude of the Ga in suspension. The negative zeta potential of 
the Gum Arabic is mainly attributed to the carboxylic groups available on its structure. 
For the case of MNP coated with Dextran, particles presented zeta potential of -1.88 
mV which is corroborated with the values determine by Xu and co-workers (Xu et al., 
2005). Dextran is a neutral polysaccharide and when the bare MNP are well coated 
with this biopolymer the zeta potential became all most zero because of the neutral 
charge of the biopolymer. 
MNPs coated with EPS became less negative when compared with the bare MNP 
particles. This also can be explained because of the zeta potential value of the EPS in 
suspension, determine in Marcos, 2010. EPS has a zeta potential of -10 mV and when 
the particles were covered with this biopolymer the zeta potential is -15 mV. This once 
again indicates that MNP were probably not completely covered with EPS. 
When particles are aminated different behaviors are observed depending on the 
supports that are being analyzed and once again this behavior is dependent on the 
charge of the biopolymer used to cover the bare MNP. In the case of MNP_Ga the 
amination step does not seem to have a considerable effect on the zeta potential 
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values. This might be explained by the fact that the Ga has a negatively surface and the 
amount of amines functionalized by the amination step is not enough to change the 
charge of the surface. These results have already been demonstrated in other works 
(Batalha et al., 2010). 
For the case of the MNP_Dex and MNP_EPS the amination step increases the density 
of amines on the surface of the supports which alters the charge of the surface of the 
carriers from negative to positive. This probably can be explained by the fact that the 
dextran is a biopolymer with a neutral charge and the EPS has a low quantity of 
carboxylic groups on its surface which can be easily dominated by the positive charge 
of the amine groups. For bare MNP, according to the literature works when these 
particles are aminated they also became positively charged (9 mV) (Batalha et al., 
2010). 
Finally, the zeta potential value for the carbon coated nanoparticles is in the same 
magnitude of order of the bare MNP considering the error associated to this value. 
Since through this coating method the majority of the groups added to the surface of 
the particles are hydroxyl groups, as previously discussed, it would be expected that 
these particles presented zeta potential values less negative. This might be indicative 
that the coating of the particles was not well done and the majority of the magnetite 
core is exposed. However, these were preliminary studies and more characterization 
methods and probably a quantification method to confirm if the particles were coated 
with glucose should be tested to understand better the phenomena involving this new 
support. 
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3.3 Conclusions 
Iron oxide nanoparticles coated with three different biopolymers, Gum Arabic, 
Dextran and Extracellular Polysaccharide have been synthesized by the co-
precipitation method with an in-situ surface coating strategy. By quantifying the 
amount of biopolymer bound to magnetite it was concluded that about 80%, 90% and 
16% of the MNPs surface were coated with Ga, Dex and EPS, respectively. The 
synthesis of MNP_EPS must be improved in order to increase the quantity of 
biopolymer coating the surface of the particles and thus improve the stability of the 
support. Also, the characterization of these supports in terms of hydrodynamic 
diameter and zeta potential values confirmed the coating with the biopolymers and 
further chemical modifications. 
In terms of stability to storage and chemical modification, all the supports revealed to 
be extremely stable. However, in future studies, it would be interesting to test the 
stability of these supports to different temperatures and solvents, in order to increase 
the range of applicability and to study in more detail each of these carriers. 
Finally, a preliminary attempt for bare MNP become resistant to oxidation and to acid 
conditions was performed but further studies must be conducted in the future to 
optimize this procedure. 
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4 MAGNETIC NANOPARTICLES 
APPLIED ON BIOCATALYSIS 
This chapter focuses on the application of magnetic nanoparticles in the 
biocatalysis field, specifically in Enterokinase immobilization onto MNPs. The 
results for the activity and stability of  Enterokinase immobilized on three 
different magnetic supports through two different chemistries  are discussed. 
Finally some conclusions about the best support for the immobilization of 
Enterokinase are presented. 
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4.1 Introduction 
Recombinant proteins of therapeutic importance such as antibodies and growth 
hormones represent and important class of biopharmaceuticals (Kubitzki et al., 2008). 
This implies that the quality, safety and efficacy of these products need to be 
extremely controlled (Clonis, 2006). 
In order to obtain high-throughput purification of the products of interest, the use of 
affinity-tag systems bring a lot of advantages. Specifically, the purification of 
recombinant proteins can be done in one-step and on a simple and precise way 
(Terpe, 2003). However, due to the therapeutic applications of these products, the 
affinity tags need to be further removed after protein purification. This can be carried 
out by harsh chemical treatments (e.g. cyanogen bromide) or by enzymatic cleavage 
that is by far more specific and less detrimental for the target protein, due to the 
milder reaction conditions. Enzymes are highly efficient reagents, but usually costly 
and labile (Arnau et al., 2006; Kubitzki et al., 2008). 
To improve stability, easy recovery and reutilization of the biocatalyst it is common to 
immobilize enzymes on solid supports. Recently magnetic nanoparticles attracted 
attention as possible solid supports for enzyme immobilization, as they provide 
minimum diffusion limitations, maximum surface area per unit mass, easy recovery 
and high enzyme loading (Kim et al., 2006). 
Kubitzki and co-workers performed studies with EK immobilized on commercial 
paramagnetic microspheres and hexamethylamino sepabeads for the cleavage of 
mucin fusion protein, which highlights the potential applications of EK systems for 
the production of biopharmaceuticals (Kubitzki et al., 2008; Kubitzki et al., 2009). In 
this work, EK was immobilized on MNPs with the intent of cleaving a fusion protein 
tag, as schematized in Figure 4.1. 
Figure 4.1 Schematic representation of a biocatalysis process using iron oxide magnetic 
nanoparticles for the immobilization of enzymes and cleavage of tag protein fusion.  
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4.2 Results and Discussion 
In this work, three different magnetic supports, previously studied in chapter 3, were 
used for the covalent immobilization of EK, an endopeptidase that recognizes the 
DDDDK sequence and is commonly utilized for the cleavage of tags in recombinant 
fusion proteins (Kubitzki et al., 2008). The enzyme immobilized on magnetic supports 
was tested with a synthetic substrate and two different model proteins in order to 
evaluate EK activity and stability when immobilized. 
4.2.1 Molecular Structure Analysis and Covalent Immobilization 
of Enterokinase 
The catalytic subunit of EK was analyzed by PyMOL to understand which would be 
the best methodologies to immobilize this enzyme. 
By analyzing the existing cysteine groups on the surface of the catalytic subunit 
(Figure 4.2) it is possible to observe a total of nine cysteine groups available. All the 
cysteine residues establish disulfide bonds between them except residue 122 marked 
with a red circle. This residue is responsible to bind the heavy subunit to the catalytic 
subunit by a disulfide bond. In this work only the catalytic subunit of the enzyme will 
be used and therefore residue 122 is available to immobilize EK on MNPs. This method 
was called Sulfo Coupling. It consists on the immobilization of EK through the 
sulfhydryl group available, mimicking the flexibility of the enzyme in its native 
structure when it is bound to the heavy subunit. For the immobilization of this 
enzyme on magnetic nanoparticles through the Sulfo Coupling method the functional 
groups of the carrier were activated with 4-(N-Maleimidomethyl)cyclohexane-1-
carboxylic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt (Sulfo – SMCC). This 
is a water-soluble crosslinker which contains an amine-reactive N-hydroxysuccinimide 
(NHS ester) and a sulfhydryl-reactive maleimide group. The NHS esters react with the 
primary amines of MNPs to form stable amide bonds, while the maleimide react with 
sulfhydryl group of EK to form stable thioether bonds, as represented in Figure 2.2. 
After immobilizing the enzyme a post-treatment with cysteine is convenient to block 
the remaining thiol groups available on the surface of the supports. 
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For a second strategy to immobilize EK on the surface of magnetic nanoparticles the 
catalytic subunit of this enzyme was analyzed in terms of the percentage of carboxylic 
and amine groups available, as shown in Figure 4.3. There are a higher number of 
carboxylic groups (aspartic acid and glutamic acid residues), when compared with the 
amine groups available (lysine and arginine residues). However, since the intent is to 
immobilize the enzyme on a solid support, only the surface available residues will be 
considered. In addition, the residues close to the binding site were also discarded 
since these might be essential for the catalytic function of the enzyme. As summarized 
on Table 4.1, 58% of the carboxylic groups are available on the surface when compared 
with the 24% of the amine groups available. Taking into account the estimated values, 
the method applied to immobilize EK was based on the carboxylic groups available on 
the surface of the enzyme and was called EDC Coupling. 
The EDC coupling method consists on the reaction of the crosslinker N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide with the carboxylic groups available on 
the surface of EK to form a reactive o-acylisourea intermediate. This intermediate 
reacts with amines on the magnetic nanoparticles forming a stable amine bond 
between the enzyme and the MNPs. The schematic representation of the EDC 
coupling method to immobilize EK onto magnetic nanoparticles is represented in 
Figure 2.2. 
Figure 4.2 Structure analysis of the catalytic subunit of 
Enterokinase: Thiol groups available on the surface of 
EK, represented in red color. This image was produced 
with the program PyMOL by making use of the 
crystalline catalytic subunit structure of EK from pdb 
(accession code 1ekb). 
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Figure 4.3 Structure analysis of the catalytic subunit of Enterokinase: A) Carboxylic groups 
available on the surface of EK, where the orange sticks represent the glutamic acid groups and 
the blue groups represent the aspartic acid residues and B) Amine groups available on the 
surface of EK, where the pink groups represent the lysine residues and the light blue represent 
the arginine groups. This image was produced with the program PyMOL by making use of the 
crystalline structure of EK from pdb (accession code 1ekb). 
 
 
 
 
 
Table 4.1 Percentage of residues and total groups available on the surface of the catalytic 
subunit of Enterokinase. Note: These values were estimated taking into account only the 
residues on the surface and discarding the residues near the binding site. 
Residues 
Percentage of residues 
on the surface 
Percentage of total groups 
available on the surface 
Aspartic acid (COOH) 55 % 
58 % 
Glutamic Acid (COOH) 62 % 
Lysine (NH2) 50 % 
24 % 
Arginine (NH2) 9 % 
B) A) 
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4.2.2 Determination of Reaction Parameters to Monitor the 
Product Released 
The activity of EK immobilized onto magnetic nanoparticles was tested with a 
microplate fluorimetry activity assay using the synthetic substrate Gly-Asp-Asp-Asp-
Asp-Lys-2-naphtylamide (GD4K-2NA). The enzyme cleaved the substrate, releasing 2-
naphtylamide (2-NA), a fluorophore that was monitored at several reaction times 
through a fluorescence assay. Before testing EK immobilized onto MNPs, the 
excitation and emission wavelengths of the reagents were determined. The calibration 
curve to quantify the product released was also studied. 
In order to determine the emission spectrum of a particular fluorophore, the 
wavelength of maximum absorption, the same as the excitation maximum, is 
determined first. To determine the excitation wavelength, several solutions of the 
product 2-NA, with different concentrations, were prepared and the absorbance was 
measured as represented in Figure 4.4. Through analysis of this figure it is possible to 
conclude that the maximum adsorption wavelength of the fluorophore 2-
naphtylamide is at 334 nm and at this wavelength the fluorophore is excited. 
After determining the excitation wavelength the emission spectra of several solutions 
of 2-NA, at different concentrations, was determined and represented in Figure 4.5. By 
analyzing the fluorescence intensity spectra of the product 2-NA it is possible to 
conclude that using 334 nm as excitation wavelength the maximum emission 
wavelength of this product is 410 nm. 
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Figure 4.4 Adsorption spectra of 2-NA solutions at different concentrations. 
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To confirm if the substrate could interfere with the fluorescence of the product 
released, solutions of the substrate (GD4K-2NA) with concentration of 1 and 0.0o1 mM 
were analyzed in terms of maximum absorption and maximum emission, respectively, 
for the same values determine for the 2-NA product. Through observation of Figure 
4.6 and Figure 4.7 it is possible to confirm that the substrate GD4K-2NA does not 
influence the absorbance and fluorescence values obtained for the product 2-NA. 
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Figure 4.6 Comparasion of the absorption values between GD4K-2NA 
and 2-NA at the same concentration (1 mM). 
Figure 4.5 Fluorescence intensity spectra of 2-NA solutions at different concentrations 
by making use of the excitation wavelength of 334 nm. 
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After determining the reaction parameters, the EK immobilized onto magnetic 
nanoparticles was tested for cleavage of the synthetic substrate GD4K-2NA, and using 
the excitation wavelength of 340 nm and emission wavelength of 430 nm, it was 
possible to monitor the released fluorophore 2-naphtylamide. The product released 
was quantified through the calibration curve where fluorescence intensity of the 2-NA 
(y-axis) was represented in function of the concentration of 2-NA in mM (x-axis). This 
curve has typical values of y = 7·106x with a correlation factor of 0.98 (Figure 4.8). 
 
Figure 4.8 Schematic representation of the action of EK immobilized on the substrate 
GD4K-2NA and consequent release and quantification of the product 2-NA obtained. 
Figure 4.7 Comparison of fluorescence intensity values between 
GD4K-2NA and 2-NA at the same concentration values (0.001 mM) 
with an excitation wavelength of 340 nm. 
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4.2.3 Activity Studies with Synthetic Substrate of Free and 
Immobilized Enterokinase 
After immobilization of Enterokinase onto magnetic nanoparticles by two different 
chemistries, the supernatants were collected and analyzed to quantify the amount of 
unbound enzyme. To perform the quantification the synthetic substrate was added to 
the supernatants and the fluorescence was monitored along the time (this procedure is 
described in section 2.2.2.iv). After a cycle of 24 hours it was possible to estimate the 
amount of enzyme immobilized in each support as represented in Figure 4.9 and 
summarized in Table 4.2. 
It was possible to immobilize more enzyme by the Sulfo coupling method. This might 
be explained by the fact that the enzyme has available amines in its structure, and the 
intermediate compound formed during EDC activation instead of reacting with the 
available amines of the support, reacts with itself and some part of the enzyme 
remains in solution and is not immobilized on the support. In addition, the 
intermediate compound of this reaction is quite unstable. Although the EDC coupling 
method yields a lower amount of immobilized enzyme, retains more activity. This 
might be explained by the fact that when enzyme is immobilized by Sulfo coupling the 
EK might suffer some conformational effect. 
Now analyzing each method in detail and starting by EDC Coupling it is possible to 
conclude that the support which immobilizes more quantity of enzyme is the 
MNP_Dex, followed by the MNP_Ga and MNP_EPS. For the case of the MNP_EPS the 
amount of EK immobilized is not measurable but the retention activity of this support 
is 28.5% (Table 4.2). This might be indicative that the method used to quantify 
enzyme is not sensitive enough to determine low quantity of enzyme immobilized. For 
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Figure 4.9 Quantity of enterokinase immobilized on magnetic 
nanoparticles by two different chemistries (n = 2). 
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this immobilization method it is also observed that the MNP_EPS retains more 
enzymatic activity, despite being the method with less quantity of enzyme 
immobilized, followed by MNP_Dex and finally by MNP_Ga. Regarding the Sulfo 
coupling it is possible to conclude that the MNP_EPS immobilizes more quantity of 
EK followed by MNP_Ga and finally by MNP_Dex. Despite the MNP_Dex presented 
less quantity of EK immobilized it is the support that presents higher enzymatic 
activity retention. 
Table 4.2 Immobilization methodologies for enterokinase to magnetic nanoparticles yielding 
the quantity of EK immobilized and activity retention. 
Note 1: The quantity of Free EK “immobilized” per µmol of NH2 available was estimated 
considering the maximum quantity of enzyme used in each immobilization (0.12 µg) and the 
maximum µmol of amines available in each support (5 µmol NH2); Note 2: The activity 
retention was calculated by the ratio between the (Activity / µmol NH2) of the immobilized EK 
and the (Activity / µmol NH2) determined for the free EK and multiplied by 100 %, where 
activity is given by the mol of product released divided per the time of reaction. The activity 
retention was calculated only for the first cycle of use of the enzyme. 
Overall and considering the quantity of enzyme used in each assay (values defined by 
the Free EK shown in the first row of Table 4.2) the MNP_EPS by Sulfo coupling 
immobilization was the support that was able to bind more enzyme. However, the 
MNP_Dex, for both immobilization methods, seems to be a better support because it 
has higher activity retention, which is preferable. Nevertheless some optimization 
studies in terms of immobilizing EK in magnetic supports should be performed 
because when compared with the literature studies, the EK immobilization on 
commercial paramagnetic microspheres and hexamethylamino sepabeads revealed an 
enzymatic activity retention of 42% and 60% (Kubitzki et al., 2008), respectively, 
which is considerably higher when compared to the values obtained for EK 
immobilized on the magnetic nanoparticles synthesized in this work. 
Method Support  
ng EK immobilized 
/ µmol NH2 
Activity 
Retention (%) 
Free Free EK 24 (Note 1) - 
EDC Coupling 
MNP_Ga 1 ± 2 1.4 % 
MNP_Dex 5 ± 7 20.4 % 
MNP_EPS 0  28.5 % 
Sulfo Coupling 
MNP_Ga 19 ± 8 0.5 % 
MNP_Dex 12 ± 17 10.5 % 
MNP_EPS 20 ± 6 1.0 % 
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EK supports were then tested in single batch reactions for 24 hours with the synthetic 
substrate GD4K-2NA. To compare and analyze the conversion of substrate, these 
assays were performed for immobilized and soluble EK. In these assays 25 µl of a 
solution 1 mM GD4K-2NA, which corresponds to 2.5 x 10
-8 mol of substrate, was used. 
Since the stoichiometry of this reaction is 1:1, if there is a conversion of 100%, in the 
end of each reaction must be quantified 2.5 x 10-8 mol of product (2-NA). These results 
were compared with the results of literature for EK immobilized on commercial 
paramagnetic microspheres and hexamethylamino sepabeads (Kubitzki et al., 2008; 
Kubitzki et al., 2009). 
When an enzyme is immobilized usually there is a reduction of the activity which 
might be compensated by an increase in stability and the potential for re-utilization. 
Through analysis of Figure 4.10 and Figure 4.11, when immobilized EK is compared 
with soluble EK1, it is possible to conclude that in the first batch there is a slight 
decrease in enzymatic activity, in both chemistries used. This might be explained by 
the immobilization effects caused on the enzyme. Due to the covalent immobilization 
of the enzyme the interaction between the support and the enzyme can modify the 
enzyme structure, which influences its activity and some denaturation might also 
occur. Also some steric hindrance effects might occur due to blocking of the active site 
of EK by adjacent functional groups or unsuitable immobilization position. Another 
effect caused by immobilization is internal mass transfer limitations that can happen 
due to some “porous” structure that the biopolymer net might create around the 
particles causing some encapsulation of the enzyme which hinders the accessibility of 
the substrate. Finally, some external diffusional limitations, despite being decreased 
by the surface area of the support used, might occur due to the difficult diffusion  of 
substrate within the liquid phase to the surface of the support (Sun and Li, 2004; 
Buchholz et al., 2005; Kubitzki et al., 2008). 
It is also possible to observe that the conversion percentage increases with the number 
of batches. This situation stands out more for the sulfo coupling but it is also 
notorious for the support MNP_EPS with EK immobilized by the EDC coupling. To 
explain this situation it is possible to predict that there is some adsorption of the 
substrate and/or product that is converted and desorb, over the number of reactions 
that occurred, this situation was already observed in other studies using EK 
immobilized due to the fact that enzyme – supports can act as a reservoir due to 
presence of a biopolymer net surrounding the MNPs (Kubitzki et al., 2009). Despite 
                                                     
1
 In the free EK assays was used 3 U of EK in each reaction, that it is, thereoretically, the 
maximum quantity of enzyme immobilized per ml of magnetic nanoparticles used. 
CHAPTER 4 - MAGNETIC NANOPARTICLES APPLIED ON BIOCATALYSIS 
69 
 
this situation, EK immobilized on magnetic nanoparticles, independently of the 
chemistry used, was re-used 10 times in repeated batch reactions, which is slightly less 
when compared with the 18 times of re-utilization of EK described in the literature 
(Kubitzki et al., 2009). 
Now looking only for the conversion of EK immobilized by the EDC coupling it is 
possible to conclude that the MNP_Ga is the support where the enzyme is less active, 
followed by the MNP_Dex. Finally, the MNP_EPS it is the support where EK has 
higher percentage of conversion of the substrate. However, the MNP_EPS is also the 
support that presents higher nonspecific adsorption due to the reasons previously 
explained. For the EDC coupling method, based on the conversion percentage 
obtained, the support MNP_Dex seems to be the best support because presents a 
higher but stable conversion without an abnormal increase along the different batches 
performed. 
For the case of the Sulfo coupling method, once again MNP_Ga is the support where 
EK had less conversion of the substrate, while the MNP_EPS is the support where EK 
had higher conversion. However, for this method for both MNP_Ga and MNP_EPS is 
observed an abnormal increase of the conversion with the number of batches that 
could be indicative of some nonspecific adsorption by these carriers. Again MNP_Dex 
revealed to be the best support for the Sulfo coupling, since it is preferable a support 
with less conversion but without nonspecific adsorption. 
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Figure 4.10 Percentage of substrate converted by EK immobilized on different 
magnetic supports through EDC Coupling. The reaction solution was removed 
after 24 hours and new solution was added for a new cleavage reaction. The set 
reaction conditions involved 25 µl of 1 mM GD4K-2NA in 50 mM Tris-HCl, pH 7.4 
incubated with 1 mL of magnetic support containing EK immobilized. 
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The modified supports with EK were characterized through DLS. The 
functionalization of EK seems to have different effects on the hydrodynamic diameters 
(Figure 4.12) depending on the different chemistry used to immobilize the enzyme. 
When EK is immobilized through EDC coupling the hydrodynamic diameter of these 
particles decreased. Whereas, when EK is immobilized by Sulfo coupling method the 
opposite happened, the hydrodynamic diameter slightly increased. These results are 
indicative that all the supports were functionalized with Enterokinase for both 
methodologies applied. About the zeta potential values obtained (Figure 4.13) it is also 
possible to conclude about the modification of the particles with the enzyme. The 
enzyme has an isoelectric point around 4 and at pH 7 becomes deprotonated (Faust et 
al., 1974). After amination the particles become more positive, but these amines 
groups are used to bind to EK, therefore, upon EK immobilization the particles 
became more negatively charged. Regarding these considerations, when more enzyme 
is immobilized on the supports the more the negative these support became when 
compared with the zeta potential of the aminated support in Figure 3.8. This is 
confirmed in Figure 4.13 where the supports modified by the EDC coupling present 
less quantity of enzyme immobilized and consequently more positive values for zeta 
potential and the opposite happens for the supports modified by the sulfo coupling. 
Figure 4.11 Percentage of substrate converted by EK immobilized on different 
magnetic supports through Sulfo Coupling. The reaction solution was removed 
after 24 hours and new solution was added for a new cleavage reaction. The set 
reaction conditions involved 25 µl of 1 mM GD4K-2NA in 50 mM Tris-HCl, pH 
7.4 incubated with 1 mL of magnetic support containing EK immobilized.  
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Taking into account all the presented results the MNP_Dex with EK immobilized by 
both chemistries were chosen to be the best supports and further studies with these 
two supports were performed. 
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Figure 4.12 Hydrodynamic diameter (nm) of the magnetic 
supports immobilized with EK by EDC Coupling by dynamic light 
scattering analysis (n = 2). 
Figure 4.13 Zeta Potential values at pH 7 for magnetic supports 
immobilized with EK by Sulfo Coupling by dynamic light 
scattering analysis (n = 2). 
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4.2.4 Optimization and Testing of the Best Supports Selected  
The immobilization of Enterokinase on MNP_Dex was repeated in order to optimize 
the amount and the activity of immobilized enzyme. For the case of the sulfo coupling 
no changes were made to the protocol previously followed (section 2.2.2.ii). On the 
other hand for the case of EDC coupling a different buffer was used during the 
immobilization method. A MES buffer (4-morpholinoethanesulfonic acid) was chosen 
because it is more suitable for carbodiimide reactions. Also a new reagent, N-
hydroxysuccinimide (NHS), was added in the reaction in order to improve stability of 
the intermediate compound and to enhance the conjugation to the primary amines. 
After repeating and optimizing the immobilization conditions for EK in the MNP_Dex 
supports, the quantity of EK immobilized and the activity retention were again 
calculated and discussed. 
Through analysis of Figure 4.14 and Table 4.3 it is possible to conclude that after 
optimizing the immobilization conditions of EK to MNP_Dex supports there is an 
increase in the quantity of enzyme immobilized and this increase is reflected in the 
increase of the percentage of enzymatic activity retention. However, the sulfo coupling 
method continues to yield higher quantity of enzyme immobilized but less activity 
retention which is once again indicative that the chemistry used to immobilize EK 
might change the enzyme structure. For the EDC coupling these optimization bring an 
activity retention more comparable to the 42% activity retention of EK on the 
commercial paramagnetic microspheres described on literature (Kubitzki et al., 2008). 
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Figure 4.14 Comparison of the quantity of Enterokinase immobilized on 
MNP_Dex by the two different chemistries before and after optimizing the 
immobilization conditions (n = 2). 
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Table 4.3 Immobilization methodologies for Enterokinase to magnetic nanoparticles yielding 
the quantity of EK immobilized and activity retention after optimizing immobilization 
conditions (n = 2). 
Note 1: The quantity of Free EK “immobilized” per µmol of NH2 available was estimated 
considering the maximum quantity of enzyme used in each immobilization (0.12 µg) and the 
maximum µmol of amines available in each support (5 µmol NH2); Note 2: The activity 
retention was calculated by the ratio between the (Activity / µmol NH2) of the immobilized EK 
and the (Activity / µmol NH2) determined for the free EK and multiplied by 100 %, where 
activity is given by the mol of product released divided per the time of reaction. The activity 
retention was calculated only for the first cycle of use of the enzyme.  
To proceed with the studies, each of the supports was tested with the synthetic 
substrate. After each reaction the support was washed 10 times with Tris-HCl, pH 7.4 
buffer and the fluorescence of the washes was monitored in order to improve the 
recovery of the supports and ensure that there is no product adsorbed to the supports. 
By analyzing Figure 4.15, the EDC coupling has two times more percentage of 
conversion when compared with the Sulfo coupling in the first batch. Then a decrease 
of the percentage of conversion is observed for both supports on the second and third 
batch. From the third batch onwards the conversion percentage stabilizes and it seems 
that this time there is no substrate and/or product adsorbed on the supports. Only five 
batches were tested in order confirm the conversion of the substrate by the enzyme 
and to conclude about what is the best support to proceed with further studies. 
In terms of characterization (Table 4.4), for the MNP_Dex modified by the EDC 
coupling the hydrodynamic diameter increases while for the sulfo coupling slightly 
decreases, when compared with the first immobilization method performed. In terms 
of zeta potential values in both cases the values became more negative after enzyme 
immobilization, when compared with the first immobilized method performed, what 
is suggestive that more quantity of enzyme was functionalized on the supports. 
Method Support  
ng EK immobilized 
/ µmol NH2 
Activity 
Retention (%) 
Free Free EK 24 - 
EDC Coupling MNP_Dex 21 ± 1 35 % 
Sulfo Coupling MNP_Dex 24 ± 0 19 % 
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Overall the support that best suits higher activity retention of the enzyme and higher 
conversion, but lower nonspecific adsorption is MNP_Dex with EK immobilized by the 
EDC coupling and this support was used for further studies. 
Table 4.4 Characterization of the hydrodynamic diameter (nm) and Zeta Potential (mV) values 
by DLS of MNP_Dex with EK immobilized by two different chemistries (n = 2). 
  
Method Support  
Hydrodynamic 
diameter (nm) 
Zeta Potential 
(mV) 
EDC Couplinng MNP_Dex 1531 ± 17 -15 ± 7 
Sulfo Coupling MNP_Dex 1235 ± 84 -13 ± 3 
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Figure 4.15 Percentage of substrate converted by EK immobilized on 
different MNP_Dex by the EDC and Sulfo Coupling. The reaction solution 
was removed after 24 hours and new solution was added for a new 
cleavage reaction. The set reaction conditions involved 25 µl of 1 mM 
GD4K-2NA in 50 mM Tris-HCl, pH 7.4 incubated with 1 mL of magnetic 
support containing EK immobilized. 
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4.2.5 Fusion protein cleavage by Immobilized EK 
After choosing MNP_Dex with Enterokinase immobilized by EDC coupling, a 
preliminary study with two protein models, containing the EK recognition sequence, 
was performed in order to evaluate the capacity of this support to cleave a fusion 
protein. 
One of the fusion proteins used was a Cleavage Control Protein from Novagen with a 
total molecular weight of 48 kDa. When cleaved it forms two proteolytic fragments of 
32 kDa and 16 kDa. The second protein used was a crude extract of a fusion protein 
expressed at the Biomolecular Engineering Group, FCT-UNL. This fusion protein has a 
total molecular weight of 31 kDa and when is cleaved it forms two proteolytic 
fragments, 29 kDa for the protein and 2 kDa for the tag. 
By analyzing Figure 4.16, that presents the results for the Cleavage Control Protein 
from Novagen, it is possible to observe that in the initial sample there is a band with a 
molecular weight of 48 kDa (total protein). However, the concentration of the protein 
used seems to be higher for the case of the soluble EK when compared with the 
immobilized EK. For the digestion with soluble EK (Figure 4.16– A), after 16 hours, is 
observed a band between 26 kDa and 32 kDa that corresponds to the first proteolytic 
fragment and the soluble enzyme. However, it is not possible to distinguish between 
the proteolytic fragment (32 kDa) and the enzyme (26.3 kDa), because they have 
similar molecular weights. It is also possible to observe a second band with molecular 
weight around 16 kDa that corresponds to the second fragment of the Cleavage 
Control Protein. For the case of immobilized EK (Figure 4.16– B) after digestion of the 
protein there might exist a low intense band at 32 kDa and no band at 16 kDa. This 
might be explained by different reasons. The enzyme might did not cleave the protein 
or the steric hindrance effect of the enzyme prevented the large protein to reach the 
small binding site of the enzyme, as already has been observed in literature (Kubitzki 
et al., 2008).Therefore, a band at 48 kDa should be observed after digestion and in this 
case the low intense band at 32 kDa does not correspond to a real protein band. There 
is also the possibility of not having enough concentration of Cleavage Control Protein 
and when cleaved there is not enough concentration of which fragment to appear in 
the gel. Another reason to explain this situation is the adsorption of the substrate to 
the carrier, in this case the reaction time should be increased so there is enough time 
for the reaction product formed to desorb from the support (Kubitzki et al., 2009). In 
this both case the low intense band at 32 kDa might correspond to the first proteolytic 
fragment. 
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For the case of the digestion of the second fusion protein, through analysis of Figure 
4.17, it is possible to observe that in the initial sample there are some contaminant 
proteins. However, is notorious a more intense band slightly above 25 kDa marker 
which corresponds to the molecular weight of the fusion protein used. When this 
protein is digested with the soluble or the immobilized EK (Figure 4.17 A and B) two 
bands with different intensities, depending on the digestion used, appear around the 
molecular weight of 25 kDa that might correspond to the fusion protein not cleaved 
(31 kDa), to the fragment of 29 kDa of the fusion protein or to the soluble 
Enterokinase that presents a molecular weight of 26.3 kDa (in the case of the soluble 
EK if was used). Since the cleaved fragment with 2 kDa did not appear in any of the 
gels it is not possible to conclude about the cleavage capacity of the soluble and 
immobilized EK on MNP_Dex by EDC coupling. 
Overall it was not possible to conclude about the cleavage capacity of fusion proteins 
by EK immobilized onto MNP_Dex. For the case of the Cleavage Control Protein it 
might be necessary to increase the concentration of this protein in the reaction 
mixture. Other viable option that was followed in the literature for the cleavage of 
mucin fusion protein would be to increase the reaction time to guarantee a total 
cleavage and/or desorption of the product (Kubitzki et al., 2008; Kubitzki et al., 2009). 
Whereas, for the case of the crude extract of fusion protein these tests should be 
performed with a different gel in order to confirm the presence of the second band at 
2 kDa to evaluate the cleavage capacity of EK. One viable option would be testing this 
sample in a Tris-Tricine gel which presents higher resolution for low molecular weight 
proteins and peptides. 
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Figure 4.17 Electrophoreses gel 12,5 % in denaturation conditions to verify the 
digestion of the Fusion Protein: A) Digestion of Fusion Protein by soluble 
Enterokinase and B) Digestion of Fusion Protein by immobilized Enterokinase: 
LMW (Low Molecular Weight). 
Figure 4.16 Electrophoreses gel 12,5 % in denaturation conditions to verify the 
digestion of the Cleavage Control Protein: A) Digestion of Cleavage Control Protein by 
soluble Enterokinase and B) Digestion of Cleavage Control Protein by immobilized 
Enterokinase: LMW (Low Molecular Weight). 
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4.3 Conclusions 
In this chapter, the immobilization of Enterokinase by two different chemistries in 
different magnetic supports has been studied All the supports were tested with a 
synthetic substrate and re-utilized 10 times in single batch reactions. This support also 
proved to be able to simplify the product purification since it can easily be removed 
from the reaction mixture due to its superparamagnetic properties. The EDC coupling 
retained higher activity of the immobilized enzyme and seemed to have less 
nonspecific adsorption. The best support revealed to be the MNP_Dex and some 
immobilization conditions were optimized in order to repeat the immobilization of 
Enterokinase. After this optimization, the MNP_Dex with EK immobilized by EDC 
coupling revealed to be the best support with activity retention of 35% comparable to 
the 42% of EK immobilized on commercial paramagnetic supports. A percentage of 
conversion of 0.4% when compared with the 1% of conversion of the soluble enzyme 
was obtained. These low conversion results for soluble EK reveal the instability of this 
enzyme, which makes the process of EK immobilization extremely complicated to 
achieve. The EK immobilized in magnetic supports still has some drawbacks related to 
the fact that the cleavage of large fusion proteins can become more difficult and some 
optimization is needed. 
Still, these preliminary studies using MNPs as solid supports for enzyme 
immobilization revealed to be highly attractive and promising. 
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5 MAGNETIC NANOPARTICLES 
APPLIED ON BIOSEPARATION 
This chapter focuses on the application of Magnetic Nanoparticles for 
bioseparation processes, particularly for antibody purification. Three different 
immobilization methods of l igand 22/8, known to bind antibodies,  on the three 
supports studied in chapter 3 have been explored. These supports have been 
initially tested for binding to pure human IgG solutions. Upon selection of the 
most promising magnetic support, studies with crude extracts containing 
antibodies and antibody fragments have been performed. 
  
CHAPTER 5 - MAGNETIC NANOPARTICLES APPLIED ON BIOSEPARATION 
80 
 
  
CHAPTER 5 - MAGNETIC NANOPARTICLES APPLIED ON BIOSEPARATION 
81 
 
5.1 Introduction 
The purification of antidodies from complex biological mixtures usually accounts for a 
large proportion of the total costs of production. In general the traditional processes 
involve several steps. Affinity chromatography appears as a useful technique due to its 
highly binding specificity, reduction of the nonspecific interactions, increased yield 
and better elimination of the unwanted contaminants (Roco, 2004; Roque and Lowe, 
2006; Roque et al., 2007). 
In order to improve this technique there have been progresses in finding and 
generating affinity ligands of variable complexity and selectivity for the purification of 
different biomolecules (Roque et al., 2007). 
Synthetic affinity ligands were developed for the purpose of avoiding the 
disadvantages associated to the natural biological ligands, namely, high cost 
associated to the production, problems associated with reusability and harsh 
conditions to be applied in the elution steps which can contribute to ligand leaching 
and contaminate the final product (Roque et al., 2004; Roque et al., 2007). 
Teng and co-workers designed, synthesized, characterized and immobilized a 
synthetic affinity ligand (22/8) which mimics the natural affinity receptor Protein A. 
This ligand possesses a triazine scaffold substituted with 3 – aminophenol and 4 - 
amino – 1 – naphthol and was chosen because it shows affinity for both Fab and Fc 
fragments of hIgG (Teng et al., 2000). 
The choice of the support where the ligand is immobilized is also a key step for 
binding the target molecule (Lowe et al., 2001). The immobilization of ligand 22/8 on 
agarose beads is extensively studied on literature (Teng et al., 1999; Teng et al., 2000; 
Roque and Lowe, 2006; Roque et al., 2007). However, as packed bed chromatography 
can face problems associated to column plugging, there is usually the need for the pre-
treatment of the samples, such as centrifugation, filtration and membrane separation, 
in order to eliminate cell debris or other colloidal contaminants (Bucak et al., 2003). 
Regarding these considerations, Batalha and co-workers immobilized ligand 22/8 onto 
Gum Arabic coated iron oxide MNPs. This support revealed to be an alternative that 
can be applied on high gradient magnetic fishing processes (Batalha et al., 2010).  
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5.2 Results and Discussion 
Three different magnetic supports selected and studied in chapter 3 were tested for 
the bioseparation processes. 
For separation applications a solid support must possess stability to the conditions of 
the synthesis and screening, reduced nonspecific interactions and possess chemical 
functionality for modifications (Guillier et al., 2000; Batalha et al., 2010). 
After the synthesis of the solid supports (MNP_Ga; MNP_Dex and MNP_EPS) all the 
supports were modified with amine groups as already explained in chapter 3. Some 
supports were further modified with aldehyde groups. These steps were crucial for the 
functionalization with the synthetic affinity ligand 22/8, where three different 
methods of immobilization were tested (Figure 2.3). The synthetic ligand was 
synthesized based on triazine chemistry using cyanuric chloride as the scaffold 
structure and the two chloride atoms were shifted by the amines depending on its 
reactivity (Teng et al., 1999). 
In Method A, ligand 22/8 was synthesized in solution-phase with a six carbon spacer. 
The free amine groups on the spacer served as the handle to conjugate the ligand on 
the magnetic supports (Guillier et al., 2000). 
In Method B, the ligand 22/8 was also synthesized in solution-phase but without a six 
carbon spacer. In this case, the spacer was only introduced through the amino-
silanization step. By removing the arm spacer of the ligand its solubility improved. 
Finally, for Method C ligand 22/8 is synthesized directly on the solid support. 
5.2.1 Binding Properties of Magnetic Supports to Pure Protein 
Solutions 
After modification of the different magnetic supports with the affinity ligand 22/8 
these were tested for binding to pure solutions of human IgG. The buffer conditions 
used for binding human IgG on the magnetic supports were selected according to 
previous studies using agarose as the solid support (Li et al., 1998). Li and co-workers 
concluded that the best binding buffer was 50 mM phosphate, pH 8 because the 
interactions of IgG with immobilized ligand are stronger near neutral pH and 
promoted at higher salt concentration due to the hydrophobic interactions (Li et al., 
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1998). In terms of the elution conditions, Teng and co-workers concluded that the 
buffer that has an optimum combination of yield and purity of the eluted hIgG in 
agarose was 0.1 M glycine – HCl, pH 3 (Teng et al., 2000). However, due to the leaching 
problems at acidic pH of the iron oxide MNPs, Batalha and co-workers studied several 
elution conditions for hIgG and concluded that the best alternative would be to elute 
with 50 mM glycine-NaOH, pH 11 (Batalha et al., 2010). During this work, the elution 
at basic pH was selected. During the assessment for binding human IgG the bound 
and eluted antibody was monitored by BCA method. 
Through the results in Table 5.1, bare MNP and MNP coated with the different 
biopolymers were compared with the traditional support for bioseparation processes, 
agarose. 
When compared with all the magnetic supports, bare agarose presented the lowest 
nonspecific interactions. In terms of the magnetic supports, bare MNPs are the 
supports with a less inert surface, binding 24 mg hIgG per gram of dried MNP. Most of 
the nonspecific interactions between bare iron oxide MNPs and hIgG are probably 
electrostatic. 
Through these results once again is possible to conclude that the coating of the iron 
oxide particles with biopolymers it is a crucial step, because reduces the nonspecific 
interactions when compared with bare MNPs. This reduction can be explained 
through the creation of a more hydrophilic layer around the iron oxides particles 
which makes the magnetic supports more inert. In terms of the best coating, 
MNP_Dex presented the lowest values of binding to human hIgG, followed by 
MNP_EPS and finally by MNP_Ga. This might be explained by the way the coating of 
the surface of the supports was performed. As presented on chapter 3 MNP_Dex were 
successfully coated with Dextran, which is a neutral polysaccharide so its charge is 
practically zero, which makes of this support less reactive. Whereas the MNP_Ga 
despite having a good coating its biopolymer is negatively charged so they tend to 
have available groups that can create more easily interactions, which makes of this 
support the most reactive. For the MNP_EPS this support presents most of core 
unprotected which might be responsible for most of the nonspecific interactions of 
this carrier. However, it is important to keep in mind that even when there is a 
successfully coating it is not uniform and homogeneous which creates a net with 
“porous” structures that leave the reactive iron oxide of the particles partly exposed to 
create interactions and might have some contribution in the nonspecific adsorption of 
the supports. 
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Table 5.1 Binding of hIgG to bare agarose and magnetic supports, being the agarose results 
from Batalha et al., 2010 (n = 2). 
MNP Supports mg hIgG Bound/g MNP 
Agarose 0 
Bare MNP 24 ± 2 
MNP_Ga 16 ± 1 
MNP_Dex 4 ± 4 
MNP_EPS 11 ± 2 
Afterwards, the different magnetic supports were immobilized with ligand 22/8 
through different methods they were evaluated in terms of binding hIgG from a pure 
solution, as presented in Figure 5.1 and Figure 5.2. Different coating strategies yielded 
distinct behaviors for binding to hIgG. 
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Figure 5.1 Binding of Human IgG to different solid supports modified with synthetic affinity 
ligand 22/8 (artificial protein A) - Results normalized per gram of particles used in each 
assay (n = 2). 
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For all ligand immobilization methods, MNP_Dex and MNP_EPS supports presented 
the best results of binding hIgG, when compared with MNP_Ga. The later revealed less 
capacity of binding hIgG, which might indicate that this support has less amount of 
ligand immobilized. In general MNP_Dex presented the best results for any of the 
immobilization methods performed. 
These differences are correlated with the amount of amine groups available on the 
surface of the supports. As already presented in Table 3.2, MNP_Dex presented the 
highest percentage of amination, followed by MNP_EPS and finally by MNP_Ga. In 
principle, a support with less amines has less quantity of ligand 22/8 immobilized on 
the surface of the support, which can have a direct implication on the quantity of hIgG 
bound to the support. The amount of hIgG bound on each support was normalized in 
terms of the quantity of amines available (Figure 5.2). MNP_Dex and MNP_EPS 
presented similar results, and MNP_Ga still bound less hIgG. 
In general, Method A revealed to be the less suitable method for immobilizing the 
synthetic affinity ligand, followed by Method B and method C. 
In Method A, there is the need to use a strong crosslinker (glutaraldehyde) which can 
react also with amine groups from neighboring particles, therefore reducing the 
aldehyde groups available to react with the amine groups from the ligand. In addition, 
the solubility of the ligand is very poor. For Method B, this procedure is performed at 
high temperature (80-90 °C) at which the less reactive chloride of the ligand is 
substituted. Consequently the quantity of ligand that is immobilized on the support 
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Figure 5.2 Binding of Human IgG to different solid supports modified with synthetic 
affinity ligand 22/8 (artificial protein A) – Results normalized per µmol of amine available 
in each support (n = 2). 
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may be compromised. In the case of Method C, this is a multistep reaction where the 
coupling of the triazine ring is done at 0°C through the most reactive chloride, 
therefore less likely to result in low reaction yields. 
According to what was discussed in the chapter 5.2.1 about the elution conditions, 
after performing binding hIgG to the support modified with the ligand 22/8 the 
protein recovery was studied (Figure 5.3). 
For MNP_Ga supports modified it is not possible to quantify eluted protein. This 
might indicate that the method used to quantify the amount of protein eluted is not 
sensitive enough for the small amount of protein that is recovered. The same 
conclusions are observed for the MNP_Dex and MNP_EPS with ligand 22/8 
immobilized through Method A where less amount of hIgG bound to the supports. 
For MNP_Dex, when ligand 22/8 was immobilized by method B it is possible to elute 
42 ± 1 mg hIgG eluted/g MNP which corresponds to 37%2 of the bound protein, while 
for the ligand immobilized through method C, 46% of bound protein (60.1 ± 0.7 mg 
hIgG eluted/g MNP) was eluted. 
For MNP_EPS modified with ligand 22/8, these supports eluted 60% and 40% of 
protein bound from the ligand immobilized by method B and method C, respectively. 
                                                     
2
 In all situations mentioned the % of eluted protein is calculated through the follow equation, 
(mg eluted*100)/mg bound 
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Figure 5.3 Human IgG eluted from magnetic supports at 50 mM 
Glycine – NaOH, pH 11 (n = 2). 
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As a result of these studies, MNP_Dex appears as the most promising magnetic 
supports for binding IgG through ligand 22/8. When MNP_Dex is modified with 
ligand 22/8 immobilized through Method C, this support binds 130 ± 5 mg hIgG 
bound/g MNP, and elute 60.1 ± 0.7 mg higG eluted/g MNP and presents less 
nonspecific adsorption. 
The magnetic support MNP_Dex modified with ligand 22/8 through Method C was 
utilized for further studies. The magnetic support was tested for binding to a model 
contaminant protein, Bovine Serum Albumin (BSA), for which the support should not 
present affinity. 
The magnetic support bound 12 ± 2 mg BSA bound/g MNP, a ten fold lower value 
when compared to the quantity of hIgG bound (130 ± 5 mg hIgG bound/g MNP) 
(Figure 5.4). Even when the naked supports (Bare MNP and MNP_Dex) are tested with 
BSA, these also present less nonspecific adsorption for BSA than for hIgG. 
Other study performed with MNP_Dex modified with ligand 22/8 by Method C was 
the adsorption isotherm of human IgG on this support (Figure 5.5) which was fitted in 
a Langmuir type isotherm. 
Through the fitting of the adsorption curve of hIgG, an affinity constant of 3.06×105 M-1 
(Ka) and a theoretical maximum capacity of 512 ± 19 mg hIgG adsorbed/g MNP (Qmax) 
were obtained with a correlation factor of 0.99 (Table 5.2). The affinity constant value 
is similar to the Protein A immobilized in agarose and higher than the value for ligand 
22/8 immobilized in agarose. In terms of Qmax value, the MNP_Dex modified with 
ligand 22/8 has a value nearly four times higher than the same ligand immobilized in 
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Figure 5.4 Binding of Albumine Serum Bovine and Human IgG to MNP_Dex 
modified with ligad 22/8 through the Method C (n = 2). 
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agarose and thirty times higher than the natural Protein A immobilized in agarose. 
These results suggest that the adsorbent studied in this work seems to be a potential 
option to be applied in bioseparation processes. 
 
Table 5.2 Comparison of binding isotherm of human IgG to immobilized protein A and ligand 
22/8 onto agarose (Teng et al., 2000) to ligand 22/8 immobilized on MNP_Dex through Method 
C. 
 
 
  
Parameters 
Protein A in 
agarose 
Ligand 22/8 in 
agarose 
Ligand 22/8 in 
MNP_Dex 
Ka (M
-1) 3.65 × 105 1.4 × 105 3.06 × 105 
Qmax (hIgG adsorbed 
(mg) / Support (g) 
17.0 151.9 512 
Figure 5.5 Binding of hIgG at the surface of MNP_Dex modified with ligand 22/8 by Method 
C. Representation of q (the amount of bound hIgG in equilibrium per mass of solid support) 
as function of Ceq (the concentration of hIgG in equilibrium). Experimental data was fitted 
with the expression q = (Qmax × Ceq) / (Kd + Ceq) for the Lagmuir isotherm (using the 
OriginLab 6.1 softaware), where Qmax corresponds to the maxium concentration of the 
matrix sites available to the partitioning solute (which can also be defined as the binding 
capacity of the adsorbent), and Kd is the dissociation constant. 
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The supports modified with ligand 22/8 through Method C were characterized by DLS, 
the results obtained are summarized in Figure 5.6, Table 5.3 and Figure 5.7. 
 
Table 5.3 Hydrodynamic Diameter and Polydispersity values for MNP_Dex modified with 
ligand 22/8 by Method C. 
The hydrodynamic diameter for MNP_Ga before and after being modified does not 
change considerably which might corroborate the low quantity of ligand 
functionalized in this support. For MNP_Dex and MNP_EPS, the hydrodynamic 
diameter decreases slightly upon modification with ligand 22/8. The functionalization 
with ligand 22/8 can create steric restrictions, (Batalha et al., 2010) alteration of 
surface charge or hydrophobicity which reduces the hydrodynamic diameter of the 
agglomerates. In terms of the polydispersity index this parameter continue to present 
high values, although more acceptable for MNP_Dex (0.4) which is indicative that the 
modification of the particles with the ligand 22/8 is not enough to create uniform 
particles. 
MNP Supports 
Hydrodynamic 
Diameter (nm) 
PDl 
MNP_Ga_22/8 1669 ± 906 0.6 ± 0.2 
MNP_Dex_22/8 1187 ± 154 0.4 ± 0.3 
MNP_EPS_22/8 1632 ± 107 0.97 ± 0.03 
Figure 5.6 Hydrodynamic diameter (nm) of the magnetic support modified with 
synthetic affinity ligand 22/8 through Method C by dynamic light scattering 
analysis (n = 2). 
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As already mentioned in chapter 3, since the coating with biopolymers creates 
agglomerates and the functionalization with ligand 22/8 is not enough to reduce the 
size of these agglomerates, other technique should be tested to determine the 
hydrodynamic size of the particles such as Mastersize 2000 from Malvern as previously 
referred. 
Finally in terms of zeta potential (Figure 5.7) the MNP_Ga and MNP_Dex when 
modified with ligand 22/8 became more negative and the MNP_EPS became slightly 
less negative. These changes in the zeta potential values are indicative of 
modifications in the supports because the charges in the surface rearrange due to the 
presence of new functionalization groups on the surface of the support, as already 
observed in literature (Batalha et al., 2010). 
In the future it might be useful to improve amination of the supports as an attempt to 
improve the amount of ligand immobilized which is directly related with the binding 
toward IgG. It would be also interesting to test other conditions of binding and elution 
in order to improve the quantity of antibody that is bound and recovered from the 
support. 
  
Figure 5.7 Zeta Potential values (mV) at pH 7 of the magnetic support 
modified with synthetic affinity ligand 22/8 through Method C by dynamic 
light scattering analysis (n = 2) 
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5.2.2 Binding Properties of Magnetic Supports to Crude Extracts 
After studying the supports with pure solutions of hIgG and BSA, the MNP_Dex 
particles were tested with two different crude extracts containing antibody related 
proteins. With these tests it was supposed to evaluate the binding specificity of the 
support in the presence of a mixture of different yeast and mammalian proteins, 
depending on the crude extracts used. 
The yeast crude extract contains a Single-chain antibody Fragment (scFv) 
extracellularly expressed by Pichia pastoris, kindly provided by Professor Rui Oliveira 
(Requimte, DQ, FCT-UNL). A scFv is an engineered antibody consisting of a heavy and 
a light chain variable regions connected by a peptide linker. The supernatant of this 
extract is constituted by three different forms of scFv antibody: covalent homodimer, 
associative homodimer and monomer. The monomer form of the scFv is between 25 – 
30 kDa, while the homodimer forms are around 50 kDa, although they became 
monomers with the same size under reducing conditions (Marty et al., 2001; Cunha et 
al., 2004). 
The mammalian crude extract is rich in monoclonal antibody (Mab) expressed by 
Chinese hamster ovary cells (CHO cells), kindly provided by Doutora Paula Alves 
(ITQB/IBET). These antibodies are glycoproteins with a total molecular weight of 150 
kDa. Under reducing conditions, antibody yield structures with several molecular 
weights (100 kDa; 50 kDa and 25 kDa). 
The MNP_Dex modified with ligand 22/8 by Method C was tested with 500 µL of each 
crude extract in the same conditions described for the pure solutions of hIgG. After 
the binding of the antibody to the support, this was washed five times to guarantee 
that all proteins adsorbed nonspecifically are removed. Subsequently, the total volume 
of adsorbent used in each case was divided in two vessels and two elution conditions 
were tested. The first elution condition tested was with a 50 mM Glycine – HCl, pH 3 
based on the studies of Teng and co-workers (Teng et al., 2000). The other elution 
condition was maintained according to what was explained in chapter 5.2.1 for the 
elution of pure solutions of hIgG in magnetic supports. All the samples collected, for 
both cases, were analyzed through SDS-PAGE and stained with Silver Staining because 
it is a more sensitive technique for staining proteins with capability of detecting bands 
containing less than 0.1 ng / mm2 of protein. 
Through observation of Figure 5.8 it is possible to conclude that the MNP_Dex 
modified with ligand 22/8 by Method C is able to bind and elute scFv from the crude 
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extract. The binding capacity is confirmed by the decrease in intensity of the 
flowthrough, when compared with the loading, of the bands around 25 kDa and 50 
kDa, corresponding respectively for the monomer and homodimer scFv. It was 
possible to elute the scFv at pH 11, once again confirmed by the presence of the same 
bands at 25 kDa and 50 kDa. However at pH 3 it was not possible to elute scFv because 
there are no visible bands. For the MNP_Dex, through the analysis of Figure 5.9 it is 
possible to conclude that the support is inert because in the flowthrough is observed 
that most of the scFv is collected and neither at pH 3 or 11 is observed any band at 25 
kDa and 50 kDa. 
For the case of the purification of Mabs (Figure 5.10), it is possible to conclude that the 
chosen support is also capable of binding and eluting Mabs. These conclusions are 
confirmed by the presence of two distinct bands of IgG at 25 kDa and 50 kDa in the 
lanes of the elution. For this case it was possible to elute the Mabs at pH 3 and pH 11, 
however at pH 11 it was eluted IgG in the first and second elution step and with higher 
concentration than at pH 3. The amount of support used is not enough to bind all IgG 
used in the assay, which is confirmed by the presence of the IgG bands in all washes. 
Once again the inertness of the MNP_Dex but this time against the Mabs was 
confirmed by the gel on Figure 5.11. This gel shows the presence of concentrated bands 
in the flowthrough, almost equivalent to the bands of the loading, which is indicative 
that the protein did not bind to the support and was collected in the flowthrough. 
Furthermore there is any band in the elution lanes which is indicative that there are 
any proteins bound to the support to be eluted. 
For both cases that have been studied the elution conditions at pH 3 did not reveal to 
be as good as at pH 11 as Teng and co-workers studied (Teng et al., 2000). This might 
be explained by the fact that the particles are chemically unstable at acidic pH through 
leaching of the iron, as already discussed, which effect the properties of the matrix and 
have direct influence in the elution of the product to be purified (Hermanson et al., 
1992). 
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Figure 5.8 Electrophoreses gel 12,5 % in denaturation conditions to verify the 
binding capacity and the best elution conditions for ScFv from the MNP_Dex_22/8. 
LMW (Low Molecular Weight); Loading (Sample of the crude extract incubated with 
the adsorbent); FT (Flowthrought); W1 (First Wash with Binding Buffer); W2 
(Second Wash with Binding Buffer); W3 (Third Wash with Binding Buffer); E1 (First 
Elution with 50 mM Glycine – HCl, pH 3); E2 (Second Elution with 50 mM Glycine – 
HCl, pH 3); E1* (First Elution with 50 mM Glycine – HCl, pH 11); E2* (Second Elution 
with 50 mM Glycine – HCl, pH 11). 
Figure 5.9 Electrophoreses gel 12,5 % in desnaturating conditions to verify 
the inertness of MNP_Dex for ScFv. LMW (Low Molecular Weight); Loading 
(Sample of the crude extract incubated with the adsorbent); FT 
(Flowthrought); W1 (First Wash with Binding Buffer); W2 (Second Wash 
with Binding Buffer); W3 (Third Wash with Binding Buffer); E1 (First Elution 
with 50 mM Glycine – HCl, pH 3); E1* (First Elution with 50 mM Glycine – 
HCl, pH 11). 
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Figure 5.10 Electrophoreses gel 12,5 % in denaturation conditions to verify the inertness 
of MNP_Dex for Mabs. LMW (Low Molecular Weight); Loading (Sample of the crude 
extract incubated with the adsorbent); FT (Flowthrought); W1 (First Wash with Binding 
Buffer); W2 (Second Wash with Binding Buffer); W3 (Third Wash with Binding Buffer); 
E1 (First Elution with 50 mM Glycine – HCl, pH 3); E1* (First Elution with 50 mM Glycine 
– HCl, pH 11). 
Figure 5.11 Electrophoreses gel 12,5 % in denaturation conditions to verify the 
inertness of MNP_Dex for Mabs. LMW (Low Molecular Weight); Loading (Sample 
of the crude extract incubated with the adsorbent); FT (Flowthrought); W1 (First 
Wash with Binding Buffer); W2 (Second Wash with Binding Buffer); W3 (Third 
Wash with Binding Buffer); E1 (First Elution with 50 mM Glycine – HCl, pH 3); E1* 
(First Elution with 50 mM Glycine – HCl, pH 11). 
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After confirmation by SDS-PAGE electrophoresis of the binding and elution capacity 
of the support in both crude extracts studied, the samples collected were quantified by 
the BCA method in order to determine the amount of protein bound to and eluted 
from the support. However, in any of the cases, it was not possible to quantify the 
amount of protein bound and eluted. This might be explained by the fact that was not 
used a blank control with the exactly same composition of the culture media where 
each antibody was expressed. In addition, the crude extracts used in its composition 
may have substances that cause interference to the method of quantification. For 
example, in the case of ScFv crude extract has in its composition glycerol and 
methanol that are substances that causes interference in the BCA Method. 
In terms of future works it is important to quantify the amount of protein bound to 
and eluted from the support. However, through BCA method it was not possible to 
determine theses values, so the methods that could be used to confirm and quantify 
the amount of antibody bond and eluted it is a Western Blot technique which 
separates the proteins of a certain lane of the SDS-PAGE by mass and an ELISA assay 
which is a technique used to quantify antibodies. 
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5.3 Conclusions 
The modification of the different magnetic supports, studied in the chapter 3, with the 
ligand 22/8 was performed with success. From all immobilization methods performed 
the best method turned out to be Method C, which consists in the direct synthesis of 
the ligand 22/8 on the support based on the triazine scaffold. Whereas the best 
support reveal to be the iron oxide MNPs coated with Dextran. This support was 
chosen as the best one since it was the support with the best relation of high 
specificity and low nonspecific adsorption of hIgG from pure solutions. Moreover the 
affinity constant of this new adsorbent for hIgG is superior to the results obtained for 
agarose with ligand 22/8 immobilized and comparable to the ones of Protein A also 
immobilized on agarose beads, which proves once again how promising this support 
can be. As for the studies of this support with crude extracts here the binding and 
elution capacities of scfV and Mabs were confirmed. However these assays require 
further optimization in terms of increasing the binding capacity of the support to bind 
all the antibodies available in the assay and also in terms of the ability to quantify the 
amount of protein bound to and eluted from the support. 
Overall it is possible to conclude that MNPs coated with biopolymers and immobilized 
with ligand 22/8 were found to have promising characteristics for the application of 
these adsorbents in bioseparation processes, particularly in antibody purification. 
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6 CONCLUDING REMARKS AND 
FUTURE DIRECTIONS 
This chapter delivers a summary of the work performed. It then provides 
further development highlights, which are improvements and features that 
should be taken into consideration. 
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In this work magnetic particles were investigated as a support for the immobilization 
of an enzyme, Enterokinase (EK), used for cleavage of fusion proteins after protein 
purification. Bioseparation studies were also conducted by making use of the same 
magnetic supports modified with an affinity synthetic ligand (Ligand 22/8) used for 
the purification of antibodies. 
MNPs were synthesized by the co-precipitation method and coated with different 
biopolymers (gum Arabic - Ga, dextran - Dex and extracellular polysaccharide - EPS) 
by an in-situ coating strategy. The quantity of biopolymer surrounding the particles 
was analyzed by the anthrone method and compared with the binding profiles for 
each biopolymer. EPS coating appeared as the less optimized method. The stability of 
magnetic supports towards storage and modification was also studied, showing high 
stability of the biopolymer coating in all supports. When MNPs are coated with 
biopolymers the hydrodynamic size increased for values between 1000 – 3000 nm, 
which indicates agglomeration of the particles. Besides that, the zeta potential also 
varies according to the charge of the polymer used. In the future, optimization of the 
MNP_EPS synthesis should be performed as well as more studies on characterization 
and stability of the supports, perhaps solvent, pH and temperature resistance. 
To study the application of magnetic nanoparticles to the biocatalysis field the three 
supports synthesized were immobilized with EK by two different chemistries (EDC 
and Sulfo Coupling) and the enzyme activity was tested with a synthetic substrate. A 
preliminary study with two recombinant fusion proteins was also performed. 
The immobilization methods used were selected according to the percentage of total 
groups available on the surface of the enzyme by molecular structure analysis. The 
quantity of EK immobilized was lower for the EDC coupling due to possible 
crosslinking effects, which reduce the quantity of enzyme available to be immobilized. 
However, the EDC coupling presented higher activity retention, 28.5%, compared with 
the 10.5% for the Sulfo coupling. The Sulfo coupling yielded supports with higher 
conversions but also higher nonspecific adsorption. However, when analyzing only the 
first cycle of reaction the EDC coupling presented higher conversion, but a loss of 
enzymatic activity for both methods was observed when compared with soluble EK. 
The loss of enzymatic activity upon covalent immobilization is well studied and 
reported (Buchholz et al., 2005). It is known that several effects contribute for the loss 
of activity, namely conformational (alterations on the enzyme structure), 
inaccessibility of the active site, and mass transfer limitations caused by the 
heterogeneous catalysis and perhaps by the polymeric net coating the MNPs that can 
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create “porous” structures that limit the accessibility of the substrate . This loss of 
activity was compensated by the re-utilization of the immobilized enzyme up to ten 
times. The results show that the MNP_Dex was the best support for both chemistries 
showing high activity retention and less nonspecific adsorption. Therefore, the 
methods of immobilizing EK were optimized and tested once again for more five 
cycles with the synthetic substrate. The best support for EK immobilization was the 
MNP_Dex by the EDC coupling with an activity retention comparable to the results 
obtained in the literature (Kubitzki et al., 2008). Preliminary cleavage of fusion 
recombinant proteins, were then performed with this support. However from the SDS-
PAGE gels it was not possible to conclude about the enzymatic activity of the 
immobilized support. Different reaction conditions, such as, higher concentration of 
the fusion recombinant proteins, a gel with a different reticulation degree, different 
reaction time and a higher quantity of enzyme immobilized in the support should be 
tested. Enterokinase appears as a very unstable enzyme, which is confirmed by the low 
activity presented by its soluble form, which causes the immobilization of this enzyme 
on solid supports difficult and challenging, as shown by the very few reports on the 
immobilization of EK. Previous work conducted at Biomolecular Engineering Lab has 
shown that MNPs are very suitable for immobilization of lipase. 
Finally, the applicability of the magnetic nanoparticles for bioseparation processes was 
tested trough immobilization of the synthetic ligand 22/8, by three different methods. 
All the supports were successfully modified with the synthetic affinity ligand, however 
the MNP_Dex with ligand 22/8 immobilized by triazine-based strategy (Method C) 
was the most promising support. It revealed a binding capacity of 130 ± 5 mg hIgG 
bound/g MNP and an elution capacity of 60.1 ± 0.7 mg hIgG eluted/g MNP for pure 
hIgG. In addition, this support also showed less nonspecific adsorption in the presence 
of BSA. The estimated values for maximum binding capacity and affinity constant for 
ligand 22/8 were comparable with protein A and ligand 22/8 immobilized on agarose.  
Also to prove the binding capacity of this support in real conditions a preliminary test 
using two different crude extracts containing different antibody species (Mabs and 
scFv) was conducted. These results proved the specificity and binding capacity of the 
support in the presence of a raw mixture of different proteins expressed by different 
systems. More studies need to be conducted in future in order to confirm the binding 
capacity of these supports and the purity of the recovered proteins. 
Overall, iron oxide magnetic nanoparticles revealed to be a promising alternative in 
biocatalysis and bioseparation processes, specifically for antibody purification.  
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